data_5miz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5miz _Structure_validation_residue.Date_analyzed 2017-01-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 pt -110.66 -29.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.587 0.232 . . . . 0.0 110.545 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.89 -43.52 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -69.7 -31.17 69.05 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.516 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -63.09 -43.94 97.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.374 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.28 -58.53 4.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.734 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 59.4 m -150.86 167.84 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.92 -15.82 59.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.516 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.457 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 15.3 t -170.64 -171.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 9' ' ' SER . 21.3 m 41.93 40.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.821 0.343 . . . . 0.0 111.788 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.3 t -154.17 115.08 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.103 0.477 . . . . 0.0 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -118.11 147.23 43.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.24 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 -30.93 71.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.317 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.554 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 65.7 m-85 -58.63 -8.15 1.18 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.236 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' NE2' ' CG ' ' A' ' 18' ' ' ASN . 10.9 tp60 -80.86 -24.83 38.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.4 tp -71.0 -35.0 71.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.915 -0.491 . . . . 0.0 111.179 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.2 pt-20 -67.9 -16.31 64.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.845 ' H ' HD21 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -62.57 -37.92 88.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -109.68 -34.88 6.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.565 0.621 . . . . 0.0 112.1 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.531 0.242 0 O-C-N 121.876 -0.515 . . . . 0.0 110.608 -179.59 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.21 134.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -86.87 104.61 16.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.01 119.47 2.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.456 0.646 . . . . 0.0 109.511 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -80.16 128.7 33.82 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.422 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -135.48 132.43 37.34 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.666 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 10.4 t -153.43 -175.68 5.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.286 0.565 . . . . 0.0 111.053 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.416 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -60.43 -34.9 87.25 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -58.96 -36.19 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.063 0.459 . . . . 0.0 110.135 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -68.36 -41.05 81.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.96 -39.5 90.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.326 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.59 -42.88 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.896 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.568 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 94.6 mt-10 -64.23 -43.84 93.69 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.359 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.97 -10.42 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' B' ' 13' ' ' GLU . 3.6 mm? -61.72 -27.12 68.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 6.1 p90 -48.8 -20.65 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.302 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.91 -50.27 71.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.556 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -92.1 -28.33 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 121.002 0.43 . . . . 0.0 110.746 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.223 -0.315 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.145 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tt -106.48 -28.08 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.976 0.417 . . . . 0.0 110.812 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.48 -23.77 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.19 -8.32 52.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -39.65 -62.92 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -54.27 3.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.069 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.94 167.97 20.81 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.79 86.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.811 0.815 . . . . 0.0 109.896 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.534 ' O ' HG21 ' A' ' 10' ' ' VAL . 28.4 t -138.3 -175.29 4.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 9' ' ' SER . 0.7 OUTLIER 60.24 19.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 123.449 0.468 . . . . 0.0 111.158 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.57 115.21 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.339 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.6 m -119.71 151.17 39.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.555 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -69.11 -40.55 78.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.312 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 67.2 m-85 -62.12 -32.05 72.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.66 -22.89 25.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.437 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -37.83 80.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.539 0.685 . . . . 0.0 110.538 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.7 pt-20 -66.68 -15.78 63.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.529 -177.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.827 ' H ' HD21 ' A' ' 18' ' ' ASN . 0.5 OUTLIER -66.16 -32.11 73.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -107.02 -43.43 4.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.695 0.284 . . . . 0.0 110.51 179.706 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.35 126.21 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -92.99 121.42 34.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.117 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -161.13 118.64 2.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -59.18 178.3 0.14 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.22 172.85 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.895 0.855 . . . . 0.0 112.978 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 163.0 38.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.885 -1.507 . . . . 0.0 106.991 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' B' ' 10' ' ' HIS . . . -65.34 -45.77 89.31 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.202 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -65.75 5.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.287 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.487 ' H ' ' C ' ' B' ' 8' ' ' GLY . 16.4 t60 -63.56 -42.85 98.34 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.08 -38.54 82.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.406 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.03 -40.64 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.942 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 91.0 mt-10 -44.61 -37.95 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.226 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 -8.44 1.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -61.77 -39.61 92.26 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.253 -178.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.8 m-85 -48.54 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.265 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' B' ' 15' ' ' LEU . 85.8 mt -62.52 -39.25 92.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.789 0.328 . . . . 0.0 110.557 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' B' ' 19' ' ' CYS . 7.4 p -57.3 -45.23 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 110.262 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.497 ' N ' ' CG1' ' B' ' 18' ' ' VAL . 1.1 p . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.773 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tt -106.46 -26.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.14 -31.96 49.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -83.17 -8.56 59.47 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -40.14 -39.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.977 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.69 -50.72 10.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.124 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -140.49 173.07 11.86 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.88 79.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -156.39 178.73 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 54.89 40.93 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.617 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -152.42 119.21 5.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.532 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -114.61 147.08 40.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 111.398 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.25 -38.26 89.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.786 0.803 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -59.31 -38.85 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.702 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -83.36 -20.72 33.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.294 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.04 -39.87 90.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.445 0.641 . . . . 0.0 111.025 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.32 -8.49 56.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.738 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -46.79 -20.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.54 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.514 ' CE2' ' SG ' ' A' ' 20' ' ' CYS . 7.0 p90 -123.17 -11.01 8.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' CE2' ' A' ' 19' ' ' TYR . 1.6 m . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.766 0.317 . . . . 0.0 110.489 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.49 132.26 33.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.128 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -85.46 104.68 15.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.695 ' NE2' ' HD1' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.25 116.88 2.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.798 0.809 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.695 ' HD1' ' NE2' ' B' ' 4' ' ' GLN . 0.0 OUTLIER -73.93 118.21 16.63 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.073 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 33.6 mt -149.37 131.98 15.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.303 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -151.82 -178.42 6.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -70.76 -14.46 72.81 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -65.75 -18.63 65.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 0.0 110.304 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -70.02 -41.32 74.44 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.93 -45.74 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.445 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 87.4 mt-10 -52.66 -25.29 10.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.39 -49.48 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.928 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.98 -39.84 95.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.456 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 0.1 OUTLIER -49.15 -22.32 0.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.644 -178.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 8.1 tt -63.73 -46.59 84.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.547 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.35 -34.88 71.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.298 0.571 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' B' ' 16' ' ' TYR . 37.2 t . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.423 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tt -106.27 -28.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.745 0.307 . . . . 0.0 110.953 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 m -62.94 -38.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.999 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 7' ' ' CYS . 97.5 mt-10 -65.07 -32.86 74.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.06 0.457 . . . . 0.0 110.107 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -65.91 -45.65 81.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.23 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -53.19 52.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 12.9 t -144.25 -171.23 3.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.48 -46.56 73.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p 178.94 -179.72 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.416 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t 60.98 41.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.302 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 p -158.0 118.25 3.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -116.64 148.01 41.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.013 0.435 . . . . 0.0 111.544 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.8 -37.51 82.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.695 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -59.95 -9.28 2.88 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.923 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.541 ' CA ' HE21 ' A' ' 15' ' ' GLN . 0.0 OUTLIER -87.6 -21.39 25.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.486 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -71.85 -33.82 68.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.159 0.504 . . . . 0.0 110.885 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 4.4 pt-20 -67.43 -17.18 64.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.198 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.83 ' H ' HD21 ' A' ' 18' ' ' ASN . 0.5 OUTLIER -65.79 -38.48 89.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.896 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -116.42 -5.57 11.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.134 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.702 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.1 t -88.57 130.17 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -81.87 113.04 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -160.99 113.41 1.91 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.0 109.847 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' B' ' 6' ' ' LEU . 46.3 t-80 -59.97 156.4 14.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.007 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' B' ' 5' ' ' HIS . 48.7 tp -169.52 131.66 1.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.003 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 44.3 t -149.68 167.43 26.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.537 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.609 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -61.78 -43.52 99.12 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -59.78 -35.8 75.38 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.785 -0.244 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.79 -44.23 81.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -60.88 -39.5 89.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.528 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' B' ' 16' ' ' TYR . 55.6 t -62.67 -45.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.385 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.578 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.6 mt-10 -55.62 -34.46 64.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.03 81.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 17' ' ' LEU . 86.6 mt -96.47 -9.0 30.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -50.92 -8.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.981 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' B' ' 15' ' ' LEU . 7.1 tt -60.93 -43.8 98.12 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.574 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.56 -16.43 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.11 0.481 . . . . 0.0 110.146 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 98.7 m . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.282 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 tp -106.85 -31.95 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.227 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 18.3 m -63.16 -42.74 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -69.26 -30.49 68.63 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.122 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.6 -46.84 88.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.185 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 18.8 p -74.1 -54.5 7.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.13 0.49 . . . . 0.0 110.987 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 92.9 m -143.38 168.14 20.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.893 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.37 81.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.487 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -161.1 174.53 13.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.668 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t 62.15 42.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.154 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 t -148.29 117.19 6.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.424 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -115.7 156.47 25.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.522 0.677 . . . . 0.0 111.735 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -63.36 -27.13 69.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.413 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -58.44 -27.62 64.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -84.77 -23.38 29.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.814 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.44 -37.18 71.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.87 -8.9 58.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.653 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -20.65 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.746 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CZ ' ' SG ' ' A' ' 20' ' ' CYS . 2.4 p90 -130.21 -3.14 4.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.288 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.606 ' SG ' ' CZ ' ' A' ' 19' ' ' TYR . 41.7 m . . . . . 0 C--N 1.332 -0.155 0 CA-C-O 120.732 0.301 . . . . 0.0 110.399 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.17 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.01 110.32 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.411 . . . . 0.0 110.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -60.28 156.37 15.72 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 110.004 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -59.99 161.98 6.11 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.89 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -162.54 132.27 4.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.39 122.11 45.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.972 0.415 . . . . 0.0 110.302 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' B' ' 10' ' ' HIS . . . -78.51 -50.22 6.24 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.666 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.479 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 38.2 t -49.26 -15.47 0.13 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.096 0.448 . . . . 0.0 110.481 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' B' ' 8' ' ' GLY . 68.1 m-70 -101.51 -38.48 7.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' B' ' 15' ' ' LEU . 0.2 OUTLIER -63.1 -39.47 94.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.319 179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -45.02 -63.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.983 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' B' ' 13' ' ' GLU . 1.5 pm0 -66.48 -37.12 84.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.874 0.369 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.4 ' N ' ' HG2' ' B' ' 13' ' ' GLU . . . -68.56 -18.8 64.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' B' ' 11' ' ' LEU . 57.2 tp -62.2 -45.82 91.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.394 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 9.4 p90 -86.64 -34.65 19.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.961 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.03 -46.8 85.85 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.221 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' B' ' 19' ' ' CYS . 7.7 p -69.54 -46.79 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.031 0 CA-C-O 120.614 0.245 . . . . 0.0 110.97 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.524 ' N ' ' CG1' ' B' ' 18' ' ' VAL . 6.5 m . . . . . 0 C--O 1.226 -0.183 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 tp -105.27 -29.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 120.672 0.272 . . . . 0.0 111.45 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' CYS . 20.1 m -60.36 -30.65 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.54 -18.68 65.5 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.052 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.75 -48.2 72.68 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.501 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.511 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 10.8 p -85.69 -52.44 5.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -140.41 169.42 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.3 -53.1 31.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.018 0.437 . . . . 0.0 111.179 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -159.46 178.7 9.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.555 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.14 41.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.3 t -143.93 118.23 9.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.241 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -115.31 154.23 29.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.67 0.748 . . . . 0.0 111.539 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.7 mt -76.46 -15.02 60.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.72 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.511 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 3.0 m-85 -77.71 -34.02 52.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.788 HE21 ' C ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -89.71 -26.12 20.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.648 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.606 ' N ' HE21 ' A' ' 15' ' ' GLN . 19.8 mt -61.45 -28.03 68.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.147 0.498 . . . . 0.0 111.299 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 2.1 pt-20 -68.1 -16.3 63.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.915 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.547 ' ND2' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -57.64 -18.76 22.05 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.547 ' CD1' ' ND2' ' A' ' 18' ' ' ASN . 65.9 m-85 -91.67 2.41 56.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.726 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 17' ' ' GLU . 2.0 t . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.591 0.234 . . . . 0.0 110.615 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.465 ' H2 ' ' H ' ' B' ' 2' ' ' VAL . 66.2 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . 0.465 ' H ' ' H2 ' ' B' ' 1' ' ' PHE . 76.5 t -86.86 131.05 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.222 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.611 ' N ' HD21 ' B' ' 3' ' ' ASN . 1.2 m120 -80.26 111.23 16.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.065 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -160.4 115.56 2.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.666 0.745 . . . . 0.0 109.887 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.51 163.14 16.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.64 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -167.27 139.35 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -108.84 139.59 43.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.124 0.488 . . . . 0.0 109.81 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 -49.55 6.22 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.554 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.457 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 6' ' ' CYS . 36.5 m-70 -73.57 -43.52 59.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.858 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -40.23 93.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.63 -47.04 95.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 72.6 mm-40 -70.41 -38.84 74.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.62 -7.38 58.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.74 -39.06 79.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.143 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.7 m-85 -57.7 -47.84 81.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.39 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' B' ' 17' ' ' LEU . 3.4 mm? -63.59 -42.68 98.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.82 -46.1 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.649 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.264 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.42 -26.98 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 120.576 0.227 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -59.66 -26.38 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.09 0.471 . . . . 0.0 111.056 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.46 -24.05 64.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.786 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.75 -42.69 70.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -73.38 -52.09 15.03 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.726 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -142.02 -170.97 3.26 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.75 17.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 111.605 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 10' ' ' VAL . 30.4 t -151.04 -174.53 4.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.416 ' N ' ' OG ' ' A' ' 9' ' ' SER . 33.7 m 40.53 42.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.0 t -127.63 120.1 27.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 m -113.46 153.25 28.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.788 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 13' ' ' LEU . 2.2 mm? -75.05 -41.39 59.14 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.61 -42.25 96.45 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.759 HE21 ' N ' ' A' ' 16' ' ' LEU . 1.5 pp0? -61.91 -19.39 62.63 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.241 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.759 ' N ' HE21 ' A' ' 15' ' ' GLN . 53.7 tp -81.39 -26.11 35.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.571 0.224 . . . . 0.0 111.372 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.13 -29.5 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -49.8 -21.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.601 -178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.475 ' CD2' ' C ' ' A' ' 19' ' ' TYR . 11.0 p90 -119.54 -15.8 8.96 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.79 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 72.5 t -91.66 130.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.29 105.14 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.658 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -162.42 121.04 2.2 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.019 0.824 . . . . 0.0 110.156 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -59.63 167.62 1.97 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.25 138.75 3.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.324 0.583 . . . . 0.0 110.898 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.35 131.0 55.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.572 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.14 -52.56 3.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.907 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -64.76 -14.34 58.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.205 0.526 . . . . 0.0 112.294 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -85.21 -37.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.04 -43.83 97.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.839 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.98 -41.0 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.87 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.0 mt-10 -62.87 -47.11 84.76 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.88 69.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.13 -50.29 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.52 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 3.8 p90 -76.37 -23.13 54.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.88 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -49.82 71.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.767 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.73 -50.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.504 ' O ' ' O ' ' B' ' 16' ' ' TYR . 20.9 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.453 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 tp -107.31 -29.68 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.498 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.52 -48.99 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.185 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.72 -15.66 62.71 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -75.9 -42.13 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.664 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -75.62 -54.87 6.29 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.542 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 m -145.42 172.41 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.72 -39.72 71.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -173.41 178.66 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.91 41.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 109.742 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.2 t -129.36 116.82 19.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.222 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -114.91 128.89 56.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.798 0.808 . . . . 0.0 112.504 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -50.31 14.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.693 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.62 -10.82 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.722 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.451 ' OE1' ' OH ' ' B' ' 16' ' ' TYR . 3.9 tp60 -72.57 -35.18 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 20' ' ' CYS . 90.8 mt -62.03 -44.12 97.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.794 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.47 -35.48 73.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.162 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -45.54 -38.01 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.315 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.05 -57.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' LEU . 1.2 p . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.8 131.64 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.3 117.67 23.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 111.817 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.77 137.77 55.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.683 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.23 155.54 17.32 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.334 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -169.74 129.75 1.0 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.948 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.33 168.25 20.23 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.06 -32.73 83.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.934 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.513 ' OG ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 m -53.88 -26.28 24.09 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -74.27 -43.6 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.718 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.75 -33.91 76.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.74 -46.63 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.671 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.575 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 97.4 mt-10 -61.01 -59.14 5.85 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.0 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.55 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.1 -8.88 1.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.207 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 10.0 m-85 -49.14 -26.01 2.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.355 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.3 -41.8 98.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.446 0.641 . . . . 0.0 110.199 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.36 -40.83 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.912 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' B' ' 16' ' ' TYR . 73.6 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.491 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 tp -106.94 -31.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.599 0.238 . . . . 0.0 110.969 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 7' ' ' CYS . 8.1 p -64.13 -37.86 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.044 0.45 . . . . 0.0 110.419 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.48 -25.33 65.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.719 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -64.34 -46.12 84.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.478 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 22.3 p -83.54 -52.53 6.4 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -142.34 169.96 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.06 -49.11 78.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 110.952 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -158.05 177.08 11.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.502 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 52.06 41.47 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.081 0.467 . . . . 0.0 111.75 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.85 117.69 14.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 110.319 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -115.93 157.93 23.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.521 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.2 -23.55 67.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.112 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.513 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 64.8 m-85 -59.42 -27.93 66.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.609 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.564 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.11 -23.36 26.66 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.594 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.21 -34.37 68.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.85 -13.08 61.85 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.015 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.756 ' H ' HD21 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -67.76 -22.96 65.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.818 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 74.0 m-85 -104.76 -13.66 15.82 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 72.4 m . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' B' ' 1' ' ' PHE . 60.5 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.81 129.91 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.904 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.16 128.88 34.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.341 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -157.01 114.29 3.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 109.788 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -63.73 167.27 6.07 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 tp -154.44 129.64 9.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.083 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 37.5 t -151.34 169.39 22.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 111.048 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.647 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -63.91 -28.62 73.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m -50.48 -24.62 3.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -82.0 -39.94 22.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.044 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -43.76 97.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.058 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.4 -43.4 84.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.777 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 81.8 mt-10 -56.83 -29.01 62.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.03 -45.67 9.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.65 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' B' ' 17' ' ' LEU . 55.8 tp -64.8 -34.64 78.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.441 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -51.48 -11.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.025 -177.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' B' ' 16' ' ' TYR . 52.4 tp -62.79 -44.63 95.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.59 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.27 -45.84 14.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 121.271 0.558 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' B' ' 16' ' ' TYR . 42.2 t . . . . . 0 C--O 1.224 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.925 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -107.69 -35.49 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.873 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.4 -44.61 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.676 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -71.16 -32.52 69.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.119 0.485 . . . . 0.0 109.989 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' NE2' ' B' ' 10' ' ' HIS . 58.6 tt0 -62.48 -47.04 85.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.869 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -56.62 6.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.155 0.503 . . . . 0.0 110.184 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.98 168.57 20.56 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.648 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.47 -46.93 57.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.841 0.353 . . . . 0.0 111.717 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 p -161.25 172.27 16.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 67.06 41.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.842 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 t -138.9 118.05 12.63 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.609 ' HG ' ' H ' ' A' ' 14' ' ' TYR . 30.9 t -115.07 167.3 10.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.559 0.695 . . . . 0.0 111.474 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.33 -31.99 71.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.027 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.609 ' H ' ' HG ' ' A' ' 12' ' ' SER . 56.1 m-85 -59.53 -35.5 74.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.367 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.46 -22.74 30.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.277 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.61 -40.6 92.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.723 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -72.42 -10.05 59.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.457 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 19' ' ' TYR . 47.2 t30 -64.27 -35.44 80.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.433 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 18' ' ' ASN . 53.5 m-85 -108.22 -26.63 10.48 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 0.0 110.95 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.531 0.215 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.44 -179.84 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -71.04 128.71 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -89.55 106.11 18.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.219 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.0 117.0 2.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.673 0.749 . . . . 0.0 109.567 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' HIS . . . . . 0.46 ' O ' ' NE2' ' B' ' 4' ' ' GLN . 68.9 t60 -90.18 144.02 26.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.156 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -148.55 141.81 25.12 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.103 0.478 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -108.94 114.23 27.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.528 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.51 -53.25 7.62 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.66 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 65.3 m -58.69 -33.35 70.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' HIS . . . . . 0.424 ' NE2' ' O ' ' A' ' 5' ' ' GLN . 46.1 t60 -78.71 -44.97 22.33 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.699 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.08 -42.33 98.31 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 43.2 t -60.79 -46.44 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.983 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.53 ' O ' ' CE2' ' B' ' 16' ' ' TYR . 96.9 mt-10 -70.29 -37.86 74.89 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.201 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.4 -8.8 59.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.657 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.96 -46.03 92.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.509 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' B' ' 13' ' ' GLU . 24.4 p90 -79.67 -21.64 44.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.61 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.07 -47.37 74.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.05 -47.77 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.404 0.621 . . . . 0.0 110.263 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' B' ' 16' ' ' TYR . 1.1 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.124 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 pt -110.66 -29.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.587 0.232 . . . . 0.0 110.545 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.89 -43.52 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -69.7 -31.17 69.05 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.516 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -63.09 -43.94 97.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.374 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.28 -58.53 4.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.734 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 59.4 m -150.86 167.84 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.92 -15.82 59.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.516 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.457 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 15.3 t -170.64 -171.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 9' ' ' SER . 21.3 m 41.93 40.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.821 0.343 . . . . 0.0 111.788 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.3 t -154.17 115.08 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.103 0.477 . . . . 0.0 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -118.11 147.23 43.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.24 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 -30.93 71.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.317 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.554 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 65.7 m-85 -58.63 -8.15 1.18 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.236 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' NE2' ' CG ' ' A' ' 18' ' ' ASN . 10.9 tp60 -80.86 -24.83 38.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.4 tp -71.0 -35.0 71.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.915 -0.491 . . . . 0.0 111.179 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.2 pt-20 -67.9 -16.31 64.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.845 ' H ' HD21 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -62.57 -37.92 88.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -109.68 -34.88 6.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.565 0.621 . . . . 0.0 112.1 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.5 m -101.8 160.64 14.3 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.876 -0.515 . . . . 0.0 110.608 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.567 -179.469 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.21 134.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -86.87 104.61 16.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.01 119.47 2.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.456 0.646 . . . . 0.0 109.511 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -80.16 128.7 33.82 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.422 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -135.48 132.43 37.34 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.666 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 10.4 t -153.43 -175.68 5.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.286 0.565 . . . . 0.0 111.053 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.416 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -60.43 -34.9 87.25 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -58.96 -36.19 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.063 0.459 . . . . 0.0 110.135 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -68.36 -41.05 81.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.96 -39.5 90.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.326 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.59 -42.88 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.896 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.568 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 94.6 mt-10 -64.23 -43.84 93.69 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.359 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.97 -10.42 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' B' ' 13' ' ' GLU . 3.6 mm? -61.72 -27.12 68.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 6.1 p90 -48.8 -20.65 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.302 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.91 -50.27 71.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.556 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -92.1 -28.33 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 121.002 0.43 . . . . 0.0 110.746 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 23.5 m -95.07 168.26 10.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.145 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.497 ' O ' ' NH1' ' B' ' 22' ' ' ARG . . . 77.8 17.44 78.68 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 23' ' ' GLY . 81.0 mm-40 -70.57 -47.94 57.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' B' ' 20' ' ' GLY . 91.5 mtm-85 42.35 20.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.604 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 63.22 -125.05 33.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -96.25 -7.13 36.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.655 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.77 117.46 12.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.304 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -98.59 132.53 43.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.68 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.43 150.33 28.63 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' B' ' 30' ' ' ALA . 4.2 Cg_exo -50.58 139.47 38.37 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.421 1.414 . . . . 0.0 112.047 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.484 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 23.7 pttt -54.98 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.78 0.8 . . . . 0.0 110.293 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.748 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tt -106.48 -28.08 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.976 0.417 . . . . 0.0 110.812 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.48 -23.77 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.19 -8.32 52.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -39.65 -62.92 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -54.27 3.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.069 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.94 167.97 20.81 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.79 86.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.811 0.815 . . . . 0.0 109.896 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.534 ' O ' HG21 ' A' ' 10' ' ' VAL . 28.4 t -138.3 -175.29 4.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 9' ' ' SER . 0.7 OUTLIER 60.24 19.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 123.449 0.468 . . . . 0.0 111.158 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.57 115.21 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.339 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.6 m -119.71 151.17 39.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.555 ' H ' ' CD2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -69.11 -40.55 78.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.312 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 67.2 m-85 -62.12 -32.05 72.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.546 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.66 -22.89 25.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.437 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -37.83 80.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.539 0.685 . . . . 0.0 110.538 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.7 pt-20 -66.68 -15.78 63.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.529 -177.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.827 ' H ' HD21 ' A' ' 18' ' ' ASN . 0.5 OUTLIER -66.16 -32.11 73.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -107.02 -43.43 4.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -158.69 168.15 27.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.695 0.284 . . . . 0.0 110.51 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.416 179.849 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.35 126.21 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -92.99 121.42 34.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.117 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -161.13 118.64 2.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -59.18 178.3 0.14 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.22 172.85 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.895 0.855 . . . . 0.0 112.978 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 163.0 38.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.885 -1.507 . . . . 0.0 106.991 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' B' ' 10' ' ' HIS . . . -65.34 -45.77 89.31 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.202 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -65.75 5.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.287 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.487 ' H ' ' C ' ' B' ' 8' ' ' GLY . 16.4 t60 -63.56 -42.85 98.34 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.08 -38.54 82.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.406 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.03 -40.64 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.942 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 91.0 mt-10 -44.61 -37.95 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.226 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 -8.44 1.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -61.77 -39.61 92.26 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.253 -178.207 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.8 m-85 -48.54 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.265 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' B' ' 15' ' ' LEU . 85.8 mt -62.52 -39.25 92.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.789 0.328 . . . . 0.0 110.557 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' B' ' 19' ' ' CYS . 7.4 p -57.3 -45.23 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 110.262 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.497 ' N ' ' CG1' ' B' ' 18' ' ' VAL . 1.1 p -95.53 169.06 10.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.773 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.42 -3.07 85.33 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' B' ' 23' ' ' GLY . 96.7 mt-10 -65.81 -37.47 86.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.564 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' B' ' 21' ' ' GLU . 16.5 ptm180 35.7 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 67.91 -172.32 33.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.642 ' CD2' ' N ' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -97.57 -5.81 34.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.902 -0.175 . . . . 0.0 110.53 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.06 118.21 5.58 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.61 136.2 33.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -155.77 81.52 3.85 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -50.94 139.09 42.0 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.403 2.069 . . . . 0.0 112.076 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -96.96 81.88 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.814 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.557 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tt -106.46 -26.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.14 -31.96 49.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -83.17 -8.56 59.47 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -40.14 -39.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.977 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.69 -50.72 10.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.124 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -140.49 173.07 11.86 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.88 79.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -156.39 178.73 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 54.89 40.93 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.617 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -152.42 119.21 5.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.532 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -114.61 147.08 40.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 111.398 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.25 -38.26 89.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.786 0.803 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -59.31 -38.85 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.702 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -83.36 -20.72 33.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.294 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.04 -39.87 90.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.445 0.641 . . . . 0.0 111.025 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.32 -8.49 56.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.738 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -46.79 -20.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.54 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.514 ' CE2' ' SG ' ' A' ' 20' ' ' CYS . 7.0 p90 -123.17 -11.01 8.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' B' ' 20' ' ' GLY . 1.6 m -140.97 160.55 39.84 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.766 0.317 . . . . 0.0 110.489 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.586 -179.728 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.49 132.26 33.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.128 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -85.46 104.68 15.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.695 ' NE2' ' HD1' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.25 116.88 2.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.798 0.809 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.695 ' HD1' ' NE2' ' B' ' 4' ' ' GLN . 0.0 OUTLIER -73.93 118.21 16.63 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.073 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 33.6 mt -149.37 131.98 15.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.303 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -151.82 -178.42 6.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -70.76 -14.46 72.81 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -65.75 -18.63 65.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 0.0 110.304 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -70.02 -41.32 74.44 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.93 -45.74 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.445 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 87.4 mt-10 -52.66 -25.29 10.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.39 -49.48 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.928 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.98 -39.84 95.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.456 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 0.1 OUTLIER -49.15 -22.32 0.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.644 -178.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 8.1 tt -63.73 -46.59 84.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.547 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.35 -34.88 71.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.298 0.571 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' B' ' 16' ' ' TYR . 37.2 t -94.48 168.72 10.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.423 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.596 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . 83.77 10.66 80.88 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.64 -36.4 80.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.777 0.322 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 48.59 27.08 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.31 -127.6 8.0 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' B' ' 24' ' ' PHE . 6.7 t80 -111.87 -3.54 14.85 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.247 0.546 . . . . 0.0 109.659 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -52.89 109.01 0.37 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 118.58 -1.248 . . . . 0.0 110.031 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -96.24 126.94 41.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.992 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -147.34 153.94 44.94 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.549 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -47.82 137.15 21.93 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.032 1.822 . . . . 0.0 110.985 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -142.18 84.23 1.87 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.186 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tt -106.27 -28.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.745 0.307 . . . . 0.0 110.953 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 m -62.94 -38.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.999 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 7' ' ' CYS . 97.5 mt-10 -65.07 -32.86 74.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.06 0.457 . . . . 0.0 110.107 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -65.91 -45.65 81.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.23 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -53.19 52.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 12.9 t -144.25 -171.23 3.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.48 -46.56 73.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p 178.94 -179.72 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.416 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t 60.98 41.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.302 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 p -158.0 118.25 3.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -116.64 148.01 41.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.013 0.435 . . . . 0.0 111.544 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.8 -37.51 82.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.695 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -59.95 -9.28 2.88 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.923 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.541 HE21 ' CA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -87.6 -21.39 25.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.486 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -71.85 -33.82 68.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.159 0.504 . . . . 0.0 110.885 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 4.4 pt-20 -67.43 -17.18 64.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.198 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.83 ' H ' HD21 ' A' ' 18' ' ' ASN . 0.5 OUTLIER -65.79 -38.48 89.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.896 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -116.42 -5.57 11.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.134 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.7 t -103.78 164.29 11.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 m120 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.587 -179.429 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.1 t -88.57 130.17 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -81.87 113.04 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -160.99 113.41 1.91 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.0 109.847 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' B' ' 6' ' ' LEU . 46.3 t-80 -59.97 156.4 14.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.007 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' B' ' 5' ' ' HIS . 48.7 tp -169.52 131.66 1.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.003 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 44.3 t -149.68 167.43 26.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.537 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.609 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -61.78 -43.52 99.12 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -59.78 -35.8 75.38 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.785 -0.244 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.79 -44.23 81.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -60.88 -39.5 89.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.528 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' B' ' 16' ' ' TYR . 55.6 t -62.67 -45.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.385 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.578 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.6 mt-10 -55.62 -34.46 64.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.03 81.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' B' ' 17' ' ' LEU . 86.6 mt -96.47 -9.0 30.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -50.92 -8.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.981 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' B' ' 15' ' ' LEU . 7.1 tt -60.93 -43.8 98.12 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.574 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.56 -16.43 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.11 0.481 . . . . 0.0 110.146 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 98.7 m -98.48 147.03 25.16 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.282 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.99 21.65 51.97 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' B' ' 23' ' ' GLY . 95.6 mt-10 -54.5 -44.45 72.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.541 0.21 . . . . 0.0 111.193 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 41.21 22.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 64.22 -128.9 37.04 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -110.85 20.85 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.13 114.87 2.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.513 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.75 112.23 18.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.347 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 38.8 p -153.18 149.72 22.29 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.37 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -52.58 141.25 53.29 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 C-N-CA 121.581 1.521 . . . . 0.0 110.629 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -117.0 82.38 1.8 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.605 179.672 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 tp -106.85 -31.95 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.227 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' SG ' ' A' ' 6' ' ' CYS . 18.3 m -63.16 -42.74 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -69.26 -30.49 68.63 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.122 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.6 -46.84 88.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.185 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 18.8 p -74.1 -54.5 7.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.13 0.49 . . . . 0.0 110.987 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 92.9 m -143.38 168.14 20.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.893 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.37 81.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.487 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -161.1 174.53 13.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.668 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t 62.15 42.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.154 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 t -148.29 117.19 6.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.424 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -115.7 156.47 25.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.522 0.677 . . . . 0.0 111.735 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -63.36 -27.13 69.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.413 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -58.44 -27.62 64.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -84.77 -23.38 29.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.814 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.44 -37.18 71.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.87 -8.9 58.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.653 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -20.65 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.746 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CZ ' ' SG ' ' A' ' 20' ' ' CYS . 2.4 p90 -130.21 -3.14 4.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.288 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.606 ' SG ' ' CZ ' ' A' ' 19' ' ' TYR . 41.7 m -118.46 162.26 18.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.732 0.301 . . . . 0.0 110.399 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.429 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.17 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.01 110.32 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.411 . . . . 0.0 110.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -60.28 156.37 15.72 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 110.004 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -59.99 161.98 6.11 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.89 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -162.54 132.27 4.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.39 122.11 45.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.972 0.415 . . . . 0.0 110.302 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' B' ' 10' ' ' HIS . . . -78.51 -50.22 6.24 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.666 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.479 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 38.2 t -49.26 -15.47 0.13 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.096 0.448 . . . . 0.0 110.481 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' B' ' 8' ' ' GLY . 68.1 m-70 -101.51 -38.48 7.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' B' ' 15' ' ' LEU . 0.2 OUTLIER -63.1 -39.47 94.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.319 179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -45.02 -63.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.983 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.589 ' H ' ' CD ' ' B' ' 13' ' ' GLU . 1.5 pm0 -66.48 -37.12 84.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.874 0.369 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.4 ' N ' ' HG2' ' B' ' 13' ' ' GLU . . . -68.56 -18.8 64.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' B' ' 11' ' ' LEU . 57.2 tp -62.2 -45.82 91.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.394 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 9.4 p90 -86.64 -34.65 19.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.961 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.03 -46.8 85.85 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.221 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' B' ' 19' ' ' CYS . 7.7 p -69.54 -46.79 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.031 0 CA-C-O 120.614 0.245 . . . . 0.0 110.97 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.524 ' N ' ' CG1' ' B' ' 18' ' ' VAL . 6.5 m -136.18 169.98 16.76 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.007 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.35 20.07 72.87 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' B' ' 23' ' ' GLY . 96.0 mt-10 -62.76 -41.19 99.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.617 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 41.03 24.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 59.94 -126.23 41.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.693 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 68.7 t80 -111.66 19.05 18.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.803 0.335 . . . . 0.0 110.349 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -55.42 114.06 1.67 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.272 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -99.15 116.67 31.9 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.69 158.05 21.67 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.353 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.07 144.36 46.88 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -150.46 83.79 1.36 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.441 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 tp -105.27 -29.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 120.672 0.272 . . . . 0.0 111.45 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' CYS . 20.1 m -60.36 -30.65 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.54 -18.68 65.5 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.052 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.75 -48.2 72.68 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.501 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.511 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 10.8 p -85.69 -52.44 5.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -140.41 169.42 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.3 -53.1 31.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.018 0.437 . . . . 0.0 111.179 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -159.46 178.7 9.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.555 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.14 41.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.3 t -143.93 118.23 9.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.241 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -115.31 154.23 29.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.67 0.748 . . . . 0.0 111.539 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.7 mt -76.46 -15.02 60.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.72 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.511 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 3.0 m-85 -77.71 -34.02 52.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.788 ' C ' HE21 ' A' ' 15' ' ' GLN . 0.0 OUTLIER -89.71 -26.12 20.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.648 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.606 ' N ' HE21 ' A' ' 15' ' ' GLN . 19.8 mt -61.45 -28.03 68.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.147 0.498 . . . . 0.0 111.299 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 2.1 pt-20 -68.1 -16.3 63.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.915 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.547 ' ND2' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -57.64 -18.76 22.05 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.547 ' CD1' ' ND2' ' A' ' 18' ' ' ASN . 65.9 m-85 -91.67 2.41 56.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.726 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 17' ' ' GLU . 2.0 t -157.09 149.43 23.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.591 0.234 . . . . 0.0 110.615 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.59 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.465 ' H2 ' ' H ' ' B' ' 2' ' ' VAL . 66.2 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.465 ' H ' ' H2 ' ' B' ' 1' ' ' PHE . 76.5 t -86.86 131.05 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.222 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.611 HD21 ' N ' ' B' ' 3' ' ' ASN . 1.2 m120 -80.26 111.23 16.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.065 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -160.4 115.56 2.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.666 0.745 . . . . 0.0 109.887 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.51 163.14 16.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.64 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -167.27 139.35 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -108.84 139.59 43.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.124 0.488 . . . . 0.0 109.81 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 -49.55 6.22 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.554 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.457 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 6' ' ' CYS . 36.5 m-70 -73.57 -43.52 59.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.858 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -40.23 93.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.63 -47.04 95.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 72.6 mm-40 -70.41 -38.84 74.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.62 -7.38 58.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.74 -39.06 79.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.143 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.7 m-85 -57.7 -47.84 81.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.39 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' B' ' 17' ' ' LEU . 3.4 mm? -63.59 -42.68 98.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.82 -46.1 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.649 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -154.96 159.25 40.25 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.264 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.42 ' O ' ' NH1' ' B' ' 22' ' ' ARG . . . 77.8 21.42 71.63 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.689 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' B' ' 17' ' ' LEU . 96.8 mt-10 -57.65 -36.33 71.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.867 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' B' ' 20' ' ' GLY . 93.0 mtm-85 48.44 35.18 5.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.035 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.79 -123.83 16.42 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.702 ' CD1' ' O ' ' B' ' 24' ' ' PHE . 0.5 OUTLIER -111.32 12.7 21.64 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -50.86 112.13 0.66 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.261 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -84.12 104.04 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.651 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 32.2 p -155.66 83.7 3.56 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' B' ' 30' ' ' ALA . 6.0 Cg_exo -63.91 141.85 79.51 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.862 1.708 . . . . 0.0 112.017 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.466 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 11.3 pttm -55.41 80.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.298 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.622 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.42 -26.98 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 120.576 0.227 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -59.66 -26.38 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.09 0.471 . . . . 0.0 111.056 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.46 -24.05 64.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.786 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.75 -42.69 70.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -73.38 -52.09 15.03 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.726 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -142.02 -170.97 3.26 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.75 17.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 111.605 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 10' ' ' VAL . 30.4 t -151.04 -174.53 4.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.416 ' N ' ' OG ' ' A' ' 9' ' ' SER . 33.7 m 40.53 42.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.0 t -127.63 120.1 27.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 m -113.46 153.25 28.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.788 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 13' ' ' LEU . 2.2 mm? -75.05 -41.39 59.14 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.61 -42.25 96.45 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.759 HE21 ' N ' ' A' ' 16' ' ' LEU . 1.5 pp0? -61.91 -19.39 62.63 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.241 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.759 ' N ' HE21 ' A' ' 15' ' ' GLN . 53.7 tp -81.39 -26.11 35.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.571 0.224 . . . . 0.0 111.372 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.13 -29.5 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -49.8 -21.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.601 -178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.475 ' CD2' ' C ' ' A' ' 19' ' ' TYR . 11.0 p90 -119.54 -15.8 8.96 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.36 162.92 15.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.79 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.534 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 72.5 t -91.66 130.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.29 105.14 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.658 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -162.42 121.04 2.2 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.019 0.824 . . . . 0.0 110.156 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -59.63 167.62 1.97 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.25 138.75 3.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.324 0.583 . . . . 0.0 110.898 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.35 131.0 55.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.572 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.14 -52.56 3.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.907 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -64.76 -14.34 58.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.205 0.526 . . . . 0.0 112.294 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -85.21 -37.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.04 -43.83 97.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.839 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 5.1 m -69.98 -41.0 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.87 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.0 mt-10 -62.87 -47.11 84.76 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.88 69.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.13 -50.29 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.52 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 3.8 p90 -76.37 -23.13 54.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.88 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.78 -49.82 71.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.767 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.73 -50.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.504 ' O ' ' O ' ' B' ' 16' ' ' TYR . 20.9 m -101.01 169.16 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.453 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.47 13.89 79.44 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.79 -38.83 87.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.733 0.302 . . . . 0.0 111.37 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 44.35 33.22 0.82 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.39 -134.78 45.12 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.613 ' CD2' ' N ' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -109.58 -13.45 14.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.893 0.346 . . . . 0.0 110.769 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -58.94 117.55 4.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.42 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -87.88 132.8 34.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.85 154.33 72.74 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.52 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -49.29 142.63 21.61 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.171 1.914 . . . . 0.0 111.835 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.39 83.61 2.05 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.379 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.616 -179.871 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 tp -107.31 -29.68 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.498 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.52 -48.99 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.185 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.72 -15.66 62.71 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -75.9 -42.13 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.664 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -75.62 -54.87 6.29 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.542 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 m -145.42 172.41 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.72 -39.72 71.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -173.41 178.66 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.91 41.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 109.742 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.2 t -129.36 116.82 19.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.222 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -114.91 128.89 56.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.798 0.808 . . . . 0.0 112.504 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -50.31 14.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.693 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.62 -10.82 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.722 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.451 ' OE1' ' OH ' ' B' ' 16' ' ' TYR . 3.9 tp60 -72.57 -35.18 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 20' ' ' CYS . 90.8 mt -62.03 -44.12 97.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.794 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.47 -35.48 73.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.162 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -45.54 -38.01 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.315 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.05 -57.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' LEU . 1.2 p -130.08 139.26 50.98 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.8 t30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.528 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.8 131.64 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.3 117.67 23.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 111.817 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.77 137.77 55.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.683 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.23 155.54 17.32 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.334 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -169.74 129.75 1.0 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.948 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.33 168.25 20.23 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.06 -32.73 83.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.934 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.513 ' OG ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 m -53.88 -26.28 24.09 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -74.27 -43.6 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.718 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.75 -33.91 76.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -60.74 -46.63 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.671 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.575 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 97.4 mt-10 -61.01 -59.14 5.85 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.0 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.55 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.1 -8.88 1.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.207 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 10.0 m-85 -49.14 -26.01 2.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.355 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.3 -41.8 98.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.446 0.641 . . . . 0.0 110.199 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.36 -40.83 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.912 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' B' ' 16' ' ' TYR . 73.6 m -91.67 169.91 10.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.491 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.85 19.48 73.48 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -36.75 81.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 42.28 28.56 0.11 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.689 0.28 . . . . 0.0 110.682 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.17 -130.16 48.69 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.14 3.38 35.77 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.617 -0.343 . . . . 0.0 110.788 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -88.92 114.95 26.09 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.932 0.872 . . . . 0.0 111.897 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -106.25 124.06 49.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.764 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.36 150.28 23.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.025 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.21 142.35 36.36 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.278 1.319 . . . . 0.0 110.893 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.48 82.04 4.87 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.159 0.504 . . . . 0.0 109.946 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.537 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 tp -106.94 -31.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.599 0.238 . . . . 0.0 110.969 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 7' ' ' CYS . 8.1 p -64.13 -37.86 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.044 0.45 . . . . 0.0 110.419 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -67.48 -25.33 65.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.719 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -64.34 -46.12 84.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.478 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 22.3 p -83.54 -52.53 6.4 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -142.34 169.96 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.06 -49.11 78.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 110.952 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -158.05 177.08 11.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.502 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 52.06 41.47 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.081 0.467 . . . . 0.0 111.75 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.85 117.69 14.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 110.319 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -115.93 157.93 23.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.521 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.2 -23.55 67.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.112 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.513 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 64.8 m-85 -59.42 -27.93 66.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.609 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.564 ' NE2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.11 -23.36 26.66 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.594 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -72.21 -34.37 68.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -67.85 -13.08 61.85 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.015 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.756 ' H ' HD21 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -67.76 -22.96 65.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.818 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 74.0 m-85 -104.76 -13.66 15.82 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 72.4 m -155.07 172.71 17.68 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.661 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.468 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 60.5 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.81 129.91 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.904 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.16 128.88 34.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.341 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -157.01 114.29 3.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 109.788 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -63.73 167.27 6.07 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 tp -154.44 129.64 9.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.083 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 37.5 t -151.34 169.39 22.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 111.048 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.647 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -63.91 -28.62 73.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m -50.48 -24.62 3.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -82.0 -39.94 22.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.044 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.94 -43.76 97.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.058 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -68.4 -43.4 84.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.777 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 81.8 mt-10 -56.83 -29.01 62.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.03 -45.67 9.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.65 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' B' ' 17' ' ' LEU . 55.8 tp -64.8 -34.64 78.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.441 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -51.48 -11.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.025 -177.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' B' ' 16' ' ' TYR . 52.4 tp -62.79 -44.63 95.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.59 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.27 -45.84 14.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 121.271 0.558 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' B' ' 20' ' ' GLY . 42.2 t -97.79 163.83 12.64 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.925 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.492 ' N ' ' SG ' ' B' ' 19' ' ' CYS . . . 76.62 20.73 76.19 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.43 -44.41 87.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.332 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 45.31 36.84 2.46 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.662 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.92 -158.58 38.83 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.688 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 76.0 t80 -111.76 18.8 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.174 0.511 . . . . 0.0 110.084 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.35 113.11 1.28 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.238 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -90.26 128.06 36.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 5.8 p -150.12 151.65 32.25 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.312 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' B' ' 30' ' ' ALA . 3.3 Cg_exo -50.43 138.59 38.55 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.913 1.742 . . . . 0.0 111.305 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 9.8 pttm -54.87 81.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.7 0.762 . . . . 0.0 109.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.318 -0.782 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -107.69 -35.49 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.873 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 p -60.4 -44.61 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.676 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -71.16 -32.52 69.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.119 0.485 . . . . 0.0 109.989 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' NE2' ' B' ' 10' ' ' HIS . 58.6 tt0 -62.48 -47.04 85.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.869 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -56.62 6.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.155 0.503 . . . . 0.0 110.184 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.98 168.57 20.56 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.648 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.47 -46.93 57.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.841 0.353 . . . . 0.0 111.717 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 p -161.25 172.27 16.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 67.06 41.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.842 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 t -138.9 118.05 12.63 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.609 ' HG ' ' H ' ' A' ' 14' ' ' TYR . 30.9 t -115.07 167.3 10.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.559 0.695 . . . . 0.0 111.474 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.33 -31.99 71.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.027 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.609 ' H ' ' HG ' ' A' ' 12' ' ' SER . 56.1 m-85 -59.53 -35.5 74.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.367 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.46 -22.74 30.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.277 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.61 -40.6 92.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.723 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -72.42 -10.05 59.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.457 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 19' ' ' TYR . 47.2 t30 -64.27 -35.44 80.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.433 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 18' ' ' ASN . 53.5 m-85 -108.22 -26.63 10.48 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 0.0 110.95 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.69 166.59 10.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.44 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.9 t30 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.431 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -71.04 128.71 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -89.55 106.11 18.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.219 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.0 117.0 2.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.673 0.749 . . . . 0.0 109.567 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.46 ' O ' ' NE2' ' B' ' 4' ' ' GLN . 68.9 t60 -90.18 144.02 26.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.156 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -148.55 141.81 25.12 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.103 0.478 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -108.94 114.23 27.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.528 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.51 -53.25 7.62 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.66 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 65.3 m -58.69 -33.35 70.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . 0.424 ' NE2' ' O ' ' A' ' 5' ' ' GLN . 46.1 t60 -78.71 -44.97 22.33 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.699 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.08 -42.33 98.31 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 43.2 t -60.79 -46.44 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.983 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.53 ' O ' ' CE2' ' B' ' 16' ' ' TYR . 96.9 mt-10 -70.29 -37.86 74.89 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.201 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.4 -8.8 59.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.657 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.96 -46.03 92.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.509 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' B' ' 13' ' ' GLU . 24.4 p90 -79.67 -21.64 44.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.61 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.07 -47.37 74.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.05 -47.77 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.404 0.621 . . . . 0.0 110.263 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' B' ' 16' ' ' TYR . 1.1 m -103.91 155.02 18.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.124 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.21 19.43 72.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' B' ' 22' ' ' ARG . 97.6 mt-10 -56.83 -48.32 78.3 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 21' ' ' GLU . 85.7 mtp180 38.49 38.39 0.24 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.468 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.21 -119.87 12.47 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.713 ' CD2' ' O ' ' B' ' 24' ' ' PHE . 72.3 t80 -111.3 19.07 18.65 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.729 -0.277 . . . . 0.0 110.573 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -54.18 112.33 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.678 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -94.42 132.06 39.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.624 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -139.81 158.44 67.73 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.098 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.64 143.75 82.14 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.274 1.983 . . . . 0.0 112.294 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -158.54 83.44 0.83 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.746 0.784 . . . . 0.0 110.027 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.8 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.651 -179.747 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 3' ' ' VAL . 12.7 pt -110.66 -29.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.587 0.232 . . . . 0.0 110.545 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.1 p -61.89 -43.52 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.484 ' N ' HG13 ' A' ' 3' ' ' VAL . 80.5 tt0 -69.7 -31.17 69.05 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.516 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -63.09 -43.94 97.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.374 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.28 -58.53 4.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.734 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 59.4 m -150.86 167.84 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.92 -15.82 59.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.516 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.476 ' C ' HG22 ' A' ' 10' ' ' VAL . 15.3 t -170.64 -171.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG22 ' C ' ' A' ' 9' ' ' SER . 21.3 m 41.93 40.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.821 0.343 . . . . 0.0 111.788 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.3 t -154.17 115.08 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.103 0.477 . . . . 0.0 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -118.11 147.23 43.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.24 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 -30.93 71.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.317 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 65.7 m-85 -58.63 -8.15 1.18 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.236 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -80.86 -24.83 38.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.4 tp -71.0 -35.0 71.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.915 -0.491 . . . . 0.0 111.179 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.2 pt-20 -67.9 -16.31 64.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 14' ' ' TYR . 2.4 m120 -62.57 -37.92 88.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -109.68 -34.88 6.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.565 0.621 . . . . 0.0 112.1 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.531 0.242 0 O-C-N 121.876 -0.515 . . . . 0.0 110.608 -179.59 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.21 134.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -86.87 104.61 16.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.01 119.47 2.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.456 0.646 . . . . 0.0 109.511 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -80.16 128.7 33.82 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.422 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -135.48 132.43 37.34 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.666 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 10.4 t -153.43 -175.68 5.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.286 0.565 . . . . 0.0 111.053 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -60.43 -34.9 87.25 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -58.96 -36.19 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.063 0.459 . . . . 0.0 110.135 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -68.36 -41.05 81.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.96 -39.5 90.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.326 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 8' ' ' GLY . 54.8 t -64.59 -42.88 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.896 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.568 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 94.6 mt-10 -64.23 -43.84 93.69 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.359 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.97 -10.42 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' B' ' 13' ' ' GLU . 3.6 mm? -61.72 -27.12 68.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 6.1 p90 -48.8 -20.65 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.302 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.91 -50.27 71.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.556 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -92.1 -28.33 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 121.002 0.43 . . . . 0.0 110.746 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.223 -0.315 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.145 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tt -106.48 -28.08 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.976 0.417 . . . . 0.0 110.812 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.48 -23.77 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.19 -8.32 52.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -39.65 -62.92 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -54.27 3.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.069 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.94 167.97 20.81 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.79 86.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.811 0.815 . . . . 0.0 109.896 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.69 ' O ' HG22 ' A' ' 10' ' ' VAL . 28.4 t -138.3 -175.29 4.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.852 HG21 ' CE1' ' B' ' 10' ' ' HIS . 0.7 OUTLIER 60.24 19.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 123.449 0.468 . . . . 0.0 111.158 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.57 115.21 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.339 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.6 m -119.71 151.17 39.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.704 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -69.11 -40.55 78.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.312 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 67.2 m-85 -62.12 -32.05 72.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.568 HE22 ' HE2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -86.66 -22.89 25.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.437 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -68.35 -37.83 80.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.539 0.685 . . . . 0.0 110.538 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.7 pt-20 -66.68 -15.78 63.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.529 -177.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 2.1 m120 -66.16 -32.11 73.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.568 ' HE2' HE22 ' A' ' 15' ' ' GLN . 75.8 m-85 -107.02 -43.43 4.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.695 0.284 . . . . 0.0 110.51 179.706 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.35 126.21 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -92.99 121.42 34.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.117 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -161.13 118.64 2.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -59.18 178.3 0.14 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.22 172.85 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.895 0.855 . . . . 0.0 112.978 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 163.0 38.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.885 -1.507 . . . . 0.0 106.991 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' B' ' 10' ' ' HIS . . . -65.34 -45.77 89.31 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.202 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -65.75 5.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.287 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.852 ' CE1' HG21 ' A' ' 10' ' ' VAL . 16.4 t60 -63.56 -42.85 98.34 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.08 -38.54 82.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.406 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.03 -40.64 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.942 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 91.0 mt-10 -44.61 -37.95 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.226 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 -8.44 1.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.594 ' O ' HD13 ' B' ' 15' ' ' LEU . 0.2 OUTLIER -61.77 -39.61 92.26 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.253 -178.207 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.8 m-85 -48.54 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.265 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' B' ' 15' ' ' LEU . 85.8 mt -62.52 -39.25 92.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.789 0.328 . . . . 0.0 110.557 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.57 HG13 ' N ' ' B' ' 19' ' ' CYS . 7.4 p -57.3 -45.23 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 110.262 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.57 ' N ' HG13 ' B' ' 18' ' ' VAL . 1.1 p . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.773 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tt -106.46 -26.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.14 -31.96 49.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -83.17 -8.56 59.47 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -40.14 -39.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.977 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.69 -50.72 10.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.124 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -140.49 173.07 11.86 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.88 79.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -156.39 178.73 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 54.89 40.93 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.617 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -152.42 119.21 5.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.532 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -114.61 147.08 40.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 111.398 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.25 -38.26 89.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.786 0.803 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -59.31 -38.85 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.702 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -83.36 -20.72 33.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.294 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.04 -39.87 90.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.445 0.641 . . . . 0.0 111.025 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.32 -8.49 56.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.738 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -46.79 -20.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.54 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.514 ' CE2' ' SG ' ' A' ' 20' ' ' CYS . 7.0 p90 -123.17 -11.01 8.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' CE2' ' A' ' 19' ' ' TYR . 1.6 m . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.766 0.317 . . . . 0.0 110.489 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.49 132.26 33.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.128 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -85.46 104.68 15.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLN . . . . . 0.412 ' OE1' ' ND1' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.25 116.88 2.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.798 0.809 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.536 ' O ' ' ND1' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -73.93 118.21 16.63 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.073 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 33.6 mt -149.37 131.98 15.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.303 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -151.82 -178.42 6.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -70.76 -14.46 72.81 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -65.75 -18.63 65.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 0.0 110.304 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -70.02 -41.32 74.44 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.93 -45.74 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.445 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 87.4 mt-10 -52.66 -25.29 10.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.39 -49.48 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.928 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.98 -39.84 95.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.456 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 0.1 OUTLIER -49.15 -22.32 0.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.644 -178.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 8.1 tt -63.73 -46.59 84.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.547 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.35 -34.88 71.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.298 0.571 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' B' ' 16' ' ' TYR . 37.2 t . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.423 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tt -106.27 -28.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.745 0.307 . . . . 0.0 110.953 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 4' ' ' GLU . 13.6 m -62.94 -38.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.999 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.431 ' N ' HG23 ' A' ' 3' ' ' VAL . 97.5 mt-10 -65.07 -32.86 74.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.06 0.457 . . . . 0.0 110.107 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -65.91 -45.65 81.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.23 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -53.19 52.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 12.9 t -144.25 -171.23 3.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.48 -46.56 73.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p 178.94 -179.72 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.416 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t 60.98 41.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.302 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 p -158.0 118.25 3.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -116.64 148.01 41.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.013 0.435 . . . . 0.0 111.544 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.8 -37.51 82.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.695 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -59.95 -9.28 2.88 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.923 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -87.6 -21.39 25.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.486 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -71.85 -33.82 68.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.159 0.504 . . . . 0.0 110.885 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 4.4 pt-20 -67.43 -17.18 64.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.198 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.411 ' N ' ' OD1' ' A' ' 18' ' ' ASN . 1.9 m120 -65.79 -38.48 89.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.896 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -116.42 -5.57 11.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.134 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.702 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.1 t -88.57 130.17 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -81.87 113.04 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -160.99 113.41 1.91 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.0 109.847 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' B' ' 6' ' ' LEU . 46.3 t-80 -59.97 156.4 14.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.007 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' B' ' 5' ' ' HIS . 48.7 tp -169.52 131.66 1.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.003 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 44.3 t -149.68 167.43 26.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.537 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.609 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -61.78 -43.52 99.12 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -59.78 -35.8 75.38 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.785 -0.244 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.79 -44.23 81.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -60.88 -39.5 89.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.528 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' B' ' 16' ' ' TYR . 55.6 t -62.67 -45.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.385 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.578 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.6 mt-10 -55.62 -34.46 64.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.03 81.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' B' ' 17' ' ' LEU . 86.6 mt -96.47 -9.0 30.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -50.92 -8.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.981 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' B' ' 15' ' ' LEU . 7.1 tt -60.93 -43.8 98.12 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.574 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.56 -16.43 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.11 0.481 . . . . 0.0 110.146 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 98.7 m . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.282 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 tp -106.85 -31.95 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.227 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 4' ' ' GLU . 18.3 m -63.16 -42.74 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 3' ' ' VAL . 47.1 tp10 -69.26 -30.49 68.63 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.122 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.6 -46.84 88.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.185 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 18.8 p -74.1 -54.5 7.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.13 0.49 . . . . 0.0 110.987 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 92.9 m -143.38 168.14 20.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.893 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.37 81.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.487 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -161.1 174.53 13.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.668 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t 62.15 42.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.154 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 t -148.29 117.19 6.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.424 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -115.7 156.47 25.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.522 0.677 . . . . 0.0 111.735 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -63.36 -27.13 69.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.413 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -58.44 -27.62 64.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -84.77 -23.38 29.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.814 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.44 -37.18 71.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.87 -8.9 58.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.653 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -49.28 -20.65 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.746 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CZ ' ' SG ' ' A' ' 20' ' ' CYS . 2.4 p90 -130.21 -3.14 4.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.288 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.606 ' SG ' ' CZ ' ' A' ' 19' ' ' TYR . 41.7 m . . . . . 0 C--N 1.332 -0.155 0 CA-C-O 120.732 0.301 . . . . 0.0 110.399 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.17 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.01 110.32 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.411 . . . . 0.0 110.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -60.28 156.37 15.72 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 110.004 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -59.99 161.98 6.11 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.89 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -162.54 132.27 4.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.39 122.11 45.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.972 0.415 . . . . 0.0 110.302 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.455 ' C ' ' N ' ' B' ' 10' ' ' HIS . . . -78.51 -50.22 6.24 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.666 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.479 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 38.2 t -49.26 -15.47 0.13 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.096 0.448 . . . . 0.0 110.481 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.455 ' N ' ' C ' ' B' ' 8' ' ' GLY . 68.1 m-70 -101.51 -38.48 7.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.619 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -63.1 -39.47 94.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.319 179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -45.02 -63.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.983 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.68 ' CD ' ' H ' ' B' ' 13' ' ' GLU . 1.5 pm0 -66.48 -37.12 84.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.874 0.369 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.446 ' O ' HG12 ' B' ' 18' ' ' VAL . . . -68.56 -18.8 64.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' B' ' 11' ' ' LEU . 57.2 tp -62.2 -45.82 91.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.394 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 9.4 p90 -86.64 -34.65 19.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.961 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.03 -46.8 85.85 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.221 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.564 HG13 ' N ' ' B' ' 19' ' ' CYS . 7.7 p -69.54 -46.79 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.031 0 CA-C-O 120.614 0.245 . . . . 0.0 110.97 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.564 ' N ' HG13 ' B' ' 18' ' ' VAL . 6.5 m . . . . . 0 C--O 1.226 -0.183 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 tp -105.27 -29.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 120.672 0.272 . . . . 0.0 111.45 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' CYS . 20.1 m -60.36 -30.65 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.54 -18.68 65.5 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.052 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.75 -48.2 72.68 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.501 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.511 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 10.8 p -85.69 -52.44 5.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -140.41 169.42 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.3 -53.1 31.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.018 0.437 . . . . 0.0 111.179 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -159.46 178.7 9.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.555 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.14 41.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.3 t -143.93 118.23 9.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.241 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -115.31 154.23 29.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.67 0.748 . . . . 0.0 111.539 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.7 mt -76.46 -15.02 60.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.72 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.511 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 3.0 m-85 -77.71 -34.02 52.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -26.12 20.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.648 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 16' ' ' LEU . 19.8 mt -61.45 -28.03 68.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.147 0.498 . . . . 0.0 111.299 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 2.1 pt-20 -68.1 -16.3 63.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.915 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -57.64 -18.76 22.05 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -91.67 2.41 56.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.726 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 17' ' ' GLU . 2.0 t . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.591 0.234 . . . . 0.0 110.615 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.86 131.05 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.222 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -80.26 111.23 16.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.065 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -160.4 115.56 2.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.666 0.745 . . . . 0.0 109.887 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.51 163.14 16.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.64 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -167.27 139.35 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -108.84 139.59 43.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.124 0.488 . . . . 0.0 109.81 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 -49.55 6.22 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.554 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.457 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 6' ' ' CYS . 36.5 m-70 -73.57 -43.52 59.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.858 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.563 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -61.35 -40.23 93.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.63 -47.04 95.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 72.6 mm-40 -70.41 -38.84 74.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.62 -7.38 58.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.74 -39.06 79.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.143 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.7 m-85 -57.7 -47.84 81.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.39 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' B' ' 17' ' ' LEU . 3.4 mm? -63.59 -42.68 98.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.82 -46.1 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.649 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.264 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.42 -26.98 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 120.576 0.227 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -59.66 -26.38 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.09 0.471 . . . . 0.0 111.056 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.46 -24.05 64.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.786 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.75 -42.69 70.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -73.38 -52.09 15.03 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.726 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -142.02 -170.97 3.26 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.75 17.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 111.605 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 10' ' ' VAL . 30.4 t -151.04 -174.53 4.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.416 ' N ' ' OG ' ' A' ' 9' ' ' SER . 33.7 m 40.53 42.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.0 t -127.63 120.1 27.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 m -113.46 153.25 28.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.788 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.2 mm? -75.05 -41.39 59.14 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.61 -42.25 96.45 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' OE1' ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -61.91 -19.39 62.63 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.241 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.472 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 53.7 tp -81.39 -26.11 35.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.571 0.224 . . . . 0.0 111.372 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.13 -29.5 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 15' ' ' GLN . 12.4 p-10 -49.8 -21.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.601 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.475 ' CD2' ' C ' ' A' ' 19' ' ' TYR . 11.0 p90 -119.54 -15.8 8.96 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.79 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 72.5 t -91.66 130.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.29 105.14 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.658 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -162.42 121.04 2.2 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.019 0.824 . . . . 0.0 110.156 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -59.63 167.62 1.97 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.25 138.75 3.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.324 0.583 . . . . 0.0 110.898 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.35 131.0 55.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.572 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.14 -52.56 3.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.907 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -64.76 -14.34 58.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.205 0.526 . . . . 0.0 112.294 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -85.21 -37.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.04 -43.83 97.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.839 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.409 HG23 ' N ' ' B' ' 13' ' ' GLU . 5.1 m -69.98 -41.0 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.87 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.0 mt-10 -62.87 -47.11 84.76 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.88 69.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.13 -50.29 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.52 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 3.8 p90 -76.37 -23.13 54.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.88 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.507 HD13 ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -63.78 -49.82 71.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.767 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.73 -50.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.504 ' O ' ' O ' ' B' ' 16' ' ' TYR . 20.9 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.453 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 tp -107.31 -29.68 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.498 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.52 -48.99 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.185 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.72 -15.66 62.71 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -75.9 -42.13 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.664 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -75.62 -54.87 6.29 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.542 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 m -145.42 172.41 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.72 -39.72 71.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -173.41 178.66 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.91 41.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 109.742 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.2 t -129.36 116.82 19.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.222 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -114.91 128.89 56.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.798 0.808 . . . . 0.0 112.504 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.58 -50.31 14.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.693 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.62 -10.82 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.722 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' B' ' 16' ' ' TYR . 3.9 tp60 -72.57 -35.18 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.493 HD21 ' CG1' ' B' ' 12' ' ' VAL . 90.8 mt -62.03 -44.12 97.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.794 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.47 -35.48 73.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.162 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -45.54 -38.01 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.315 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.05 -57.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' LEU . 1.2 p . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.8 131.64 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.3 117.67 23.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 111.817 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.77 137.77 55.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.683 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.23 155.54 17.32 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.334 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -169.74 129.75 1.0 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.948 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.33 168.25 20.23 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.421 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -62.06 -32.73 83.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.934 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.513 ' OG ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 m -53.88 -26.28 24.09 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -74.27 -43.6 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.718 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.75 -33.91 76.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.493 ' CG1' HD21 ' A' ' 16' ' ' LEU . 69.4 t -60.74 -46.63 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.671 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.575 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 97.4 mt-10 -61.01 -59.14 5.85 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.0 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.55 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.1 -8.88 1.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.207 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 10.0 m-85 -49.14 -26.01 2.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.355 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.3 -41.8 98.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.446 0.641 . . . . 0.0 110.199 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.36 -40.83 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.912 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' B' ' 16' ' ' TYR . 73.6 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.491 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 tp -106.94 -31.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.599 0.238 . . . . 0.0 110.969 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 4' ' ' GLU . 8.1 p -64.13 -37.86 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.044 0.45 . . . . 0.0 110.419 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 3' ' ' VAL . 83.7 tt0 -67.48 -25.33 65.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.719 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -64.34 -46.12 84.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.478 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 22.3 p -83.54 -52.53 6.4 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -142.34 169.96 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.06 -49.11 78.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 110.952 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -158.05 177.08 11.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.502 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 52.06 41.47 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.081 0.467 . . . . 0.0 111.75 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.85 117.69 14.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 110.319 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -115.93 157.93 23.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.521 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -63.2 -23.55 67.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.112 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -59.42 -27.93 66.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.609 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.406 ' OE1' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.11 -23.36 26.66 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.594 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 16' ' ' LEU . 10.9 mp -72.21 -34.37 68.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 7.1 pt-20 -67.85 -13.08 61.85 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.015 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 2.0 m120 -67.76 -22.96 65.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.818 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 74.0 m-85 -104.76 -13.66 15.82 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 72.4 m . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' PHE . . . . . 0.468 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 60.5 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.81 129.91 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.904 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.16 128.88 34.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.341 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -157.01 114.29 3.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 109.788 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -63.73 167.27 6.07 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 tp -154.44 129.64 9.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.083 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 37.5 t -151.34 169.39 22.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 111.048 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.647 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -63.91 -28.62 73.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m -50.48 -24.62 3.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -82.0 -39.94 22.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.044 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.571 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -62.94 -43.76 97.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.058 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 13' ' ' GLU . 33.0 m -68.4 -43.4 84.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.777 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 81.8 mt-10 -56.83 -29.01 62.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.03 -45.67 9.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.65 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.422 ' C ' ' N ' ' B' ' 17' ' ' LEU . 55.8 tp -64.8 -34.64 78.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.441 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -51.48 -11.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.025 -177.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' B' ' 16' ' ' TYR . 52.4 tp -62.79 -44.63 95.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.59 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.27 -45.84 14.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 121.271 0.558 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' B' ' 16' ' ' TYR . 42.2 t . . . . . 0 C--O 1.224 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.925 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.578 ' O ' HD13 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -107.69 -35.49 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.873 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.7 p -60.4 -44.61 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.676 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' N ' HG13 ' A' ' 3' ' ' VAL . 42.6 tp10 -71.16 -32.52 69.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.119 0.485 . . . . 0.0 109.989 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' NE2' ' B' ' 10' ' ' HIS . 58.6 tt0 -62.48 -47.04 85.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.869 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -56.62 6.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.155 0.503 . . . . 0.0 110.184 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.98 168.57 20.56 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.648 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.47 -46.93 57.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.841 0.353 . . . . 0.0 111.717 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 p -161.25 172.27 16.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 67.06 41.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.842 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 t -138.9 118.05 12.63 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 t -115.07 167.3 10.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.559 0.695 . . . . 0.0 111.474 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.7 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.33 -31.99 71.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.027 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -59.53 -35.5 74.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -84.46 -22.74 30.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.277 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.61 -40.6 92.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.723 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -72.42 -10.05 59.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.457 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 19' ' ' TYR . 47.2 t30 -64.27 -35.44 80.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.433 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 18' ' ' ASN . 53.5 m-85 -108.22 -26.63 10.48 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 0.0 110.95 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.531 0.215 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.44 -179.84 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -71.04 128.71 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -89.55 106.11 18.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.219 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.0 117.0 2.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.673 0.749 . . . . 0.0 109.567 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -90.18 144.02 26.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.156 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -148.55 141.81 25.12 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.103 0.478 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -108.94 114.23 27.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.528 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.543 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -73.51 -53.25 7.62 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.66 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 65.3 m -58.69 -33.35 70.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' HIS . . . . . 0.424 ' NE2' ' O ' ' A' ' 5' ' ' GLN . 46.1 t60 -78.71 -44.97 22.33 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.699 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.08 -42.33 98.31 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 8' ' ' GLY . 43.2 t -60.79 -46.44 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.983 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.53 ' O ' ' CE2' ' B' ' 16' ' ' TYR . 96.9 mt-10 -70.29 -37.86 74.89 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.201 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.4 -8.8 59.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.657 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.96 -46.03 92.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.509 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' B' ' 13' ' ' GLU . 24.4 p90 -79.67 -21.64 44.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.61 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.07 -47.37 74.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.05 -47.77 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.404 0.621 . . . . 0.0 110.263 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' B' ' 16' ' ' TYR . 1.1 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.124 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 3' ' ' VAL . 12.7 pt -110.66 -29.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.587 0.232 . . . . 0.0 110.545 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.1 p -61.89 -43.52 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.484 ' N ' HG13 ' A' ' 3' ' ' VAL . 80.5 tt0 -69.7 -31.17 69.05 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.516 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -63.09 -43.94 97.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.374 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.28 -58.53 4.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.734 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 59.4 m -150.86 167.84 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.92 -15.82 59.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.516 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.476 ' C ' HG22 ' A' ' 10' ' ' VAL . 15.3 t -170.64 -171.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG22 ' C ' ' A' ' 9' ' ' SER . 21.3 m 41.93 40.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.821 0.343 . . . . 0.0 111.788 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.3 t -154.17 115.08 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.103 0.477 . . . . 0.0 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -118.11 147.23 43.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.24 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 -30.93 71.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.317 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 65.7 m-85 -58.63 -8.15 1.18 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.236 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -80.86 -24.83 38.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.4 tp -71.0 -35.0 71.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.915 -0.491 . . . . 0.0 111.179 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.2 pt-20 -67.9 -16.31 64.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 14' ' ' TYR . 2.4 m120 -62.57 -37.92 88.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -109.68 -34.88 6.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.565 0.621 . . . . 0.0 112.1 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.5 m -101.8 160.64 14.3 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.876 -0.515 . . . . 0.0 110.608 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.567 -179.469 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.21 134.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -86.87 104.61 16.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.01 119.47 2.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.456 0.646 . . . . 0.0 109.511 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -80.16 128.7 33.82 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.422 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -135.48 132.43 37.34 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.666 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 10.4 t -153.43 -175.68 5.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.286 0.565 . . . . 0.0 111.053 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -60.43 -34.9 87.25 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -58.96 -36.19 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.063 0.459 . . . . 0.0 110.135 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -68.36 -41.05 81.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.96 -39.5 90.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.326 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 8' ' ' GLY . 54.8 t -64.59 -42.88 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.896 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.568 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 94.6 mt-10 -64.23 -43.84 93.69 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.359 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.97 -10.42 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' B' ' 13' ' ' GLU . 3.6 mm? -61.72 -27.12 68.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 6.1 p90 -48.8 -20.65 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.302 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.91 -50.27 71.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.556 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -92.1 -28.33 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 121.002 0.43 . . . . 0.0 110.746 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 23.5 m -95.07 168.26 10.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.145 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.497 ' O ' ' NH1' ' B' ' 22' ' ' ARG . . . 77.8 17.44 78.68 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 23' ' ' GLY . 81.0 mm-40 -70.57 -47.94 57.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' B' ' 20' ' ' GLY . 91.5 mtm-85 42.35 20.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.604 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 63.22 -125.05 33.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -96.25 -7.13 36.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.655 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.77 117.46 12.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.304 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -98.59 132.53 43.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.68 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.43 150.33 28.63 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' B' ' 30' ' ' ALA . 4.2 Cg_exo -50.58 139.47 38.37 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.421 1.414 . . . . 0.0 112.047 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.484 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 23.7 pttt -54.98 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.78 0.8 . . . . 0.0 110.293 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.748 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tt -106.48 -28.08 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.976 0.417 . . . . 0.0 110.812 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.48 -23.77 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.19 -8.32 52.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -39.65 -62.92 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -54.27 3.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.069 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.94 167.97 20.81 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.79 86.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.811 0.815 . . . . 0.0 109.896 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.69 ' O ' HG22 ' A' ' 10' ' ' VAL . 28.4 t -138.3 -175.29 4.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.852 HG21 ' CE1' ' B' ' 10' ' ' HIS . 0.7 OUTLIER 60.24 19.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 123.449 0.468 . . . . 0.0 111.158 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.57 115.21 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.339 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.6 m -119.71 151.17 39.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -69.11 -40.55 78.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.312 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 67.2 m-85 -62.12 -32.05 72.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.568 HE22 ' HE2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -86.66 -22.89 25.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.437 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -68.35 -37.83 80.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.539 0.685 . . . . 0.0 110.538 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.7 pt-20 -66.68 -15.78 63.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.529 -177.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 2.1 m120 -66.16 -32.11 73.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.568 ' HE2' HE22 ' A' ' 15' ' ' GLN . 75.8 m-85 -107.02 -43.43 4.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -158.69 168.15 27.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.695 0.284 . . . . 0.0 110.51 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.535 ' OXT' ' ND2' ' A' ' 21' ' ' ASN . 3.4 t30 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.416 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.35 126.21 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -92.99 121.42 34.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.117 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -161.13 118.64 2.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -59.18 178.3 0.14 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.22 172.85 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.895 0.855 . . . . 0.0 112.978 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 163.0 38.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.885 -1.507 . . . . 0.0 106.991 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' B' ' 10' ' ' HIS . . . -65.34 -45.77 89.31 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.202 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -65.75 5.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.287 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.852 ' CE1' HG21 ' A' ' 10' ' ' VAL . 16.4 t60 -63.56 -42.85 98.34 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.08 -38.54 82.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.406 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.03 -40.64 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.942 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 91.0 mt-10 -44.61 -37.95 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.226 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 -8.44 1.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.594 ' O ' HD13 ' B' ' 15' ' ' LEU . 0.2 OUTLIER -61.77 -39.61 92.26 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.253 -178.207 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.8 m-85 -48.54 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.265 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' B' ' 15' ' ' LEU . 85.8 mt -62.52 -39.25 92.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.789 0.328 . . . . 0.0 110.557 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.57 HG13 ' N ' ' B' ' 19' ' ' CYS . 7.4 p -57.3 -45.23 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 110.262 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.57 ' N ' HG13 ' B' ' 18' ' ' VAL . 1.1 p -95.53 169.06 10.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.773 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.42 -3.07 85.33 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' B' ' 23' ' ' GLY . 96.7 mt-10 -65.81 -37.47 86.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.564 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' B' ' 21' ' ' GLU . 16.5 ptm180 35.7 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 67.91 -172.32 33.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.642 ' CD2' ' N ' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -97.57 -5.81 34.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.902 -0.175 . . . . 0.0 110.53 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.06 118.21 5.58 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.61 136.2 33.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -155.77 81.52 3.85 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -50.94 139.09 42.0 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.403 2.069 . . . . 0.0 112.076 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -96.96 81.88 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.814 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.557 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tt -106.46 -26.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.14 -31.96 49.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -83.17 -8.56 59.47 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -40.14 -39.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.977 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.69 -50.72 10.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.124 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -140.49 173.07 11.86 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.88 79.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -156.39 178.73 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 54.89 40.93 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.617 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -152.42 119.21 5.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.532 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -114.61 147.08 40.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 111.398 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.25 -38.26 89.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.786 0.803 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -59.31 -38.85 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.702 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -83.36 -20.72 33.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.294 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.04 -39.87 90.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.445 0.641 . . . . 0.0 111.025 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.32 -8.49 56.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.738 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -46.79 -20.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.54 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.514 ' CE2' ' SG ' ' A' ' 20' ' ' CYS . 7.0 p90 -123.17 -11.01 8.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' B' ' 20' ' ' GLY . 1.6 m -140.97 160.55 39.84 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.766 0.317 . . . . 0.0 110.489 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.586 -179.728 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.49 132.26 33.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.128 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -85.46 104.68 15.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.412 ' OE1' ' ND1' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.25 116.88 2.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.798 0.809 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.536 ' O ' ' ND1' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -73.93 118.21 16.63 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.073 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 33.6 mt -149.37 131.98 15.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.303 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -151.82 -178.42 6.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -70.76 -14.46 72.81 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -65.75 -18.63 65.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 0.0 110.304 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -70.02 -41.32 74.44 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.93 -45.74 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.445 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 87.4 mt-10 -52.66 -25.29 10.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.39 -49.48 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.928 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.98 -39.84 95.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.456 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 0.1 OUTLIER -49.15 -22.32 0.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.644 -178.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 8.1 tt -63.73 -46.59 84.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.547 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.35 -34.88 71.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.298 0.571 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' B' ' 16' ' ' TYR . 37.2 t -94.48 168.72 10.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.423 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.596 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . 83.77 10.66 80.88 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.64 -36.4 80.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.777 0.322 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 48.59 27.08 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.31 -127.6 8.0 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' B' ' 24' ' ' PHE . 6.7 t80 -111.87 -3.54 14.85 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.247 0.546 . . . . 0.0 109.659 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -52.89 109.01 0.37 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 118.58 -1.248 . . . . 0.0 110.031 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -96.24 126.94 41.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.992 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -147.34 153.94 44.94 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.549 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -47.82 137.15 21.93 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.032 1.822 . . . . 0.0 110.985 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -142.18 84.23 1.87 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.186 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tt -106.27 -28.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.745 0.307 . . . . 0.0 110.953 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 4' ' ' GLU . 13.6 m -62.94 -38.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.999 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.431 ' N ' HG23 ' A' ' 3' ' ' VAL . 97.5 mt-10 -65.07 -32.86 74.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.06 0.457 . . . . 0.0 110.107 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -65.91 -45.65 81.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.23 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -53.19 52.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 12.9 t -144.25 -171.23 3.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.48 -46.56 73.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p 178.94 -179.72 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.416 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t 60.98 41.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.302 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 8.1 p -158.0 118.25 3.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -116.64 148.01 41.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.013 0.435 . . . . 0.0 111.544 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.8 -37.51 82.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.695 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -59.95 -9.28 2.88 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.923 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -87.6 -21.39 25.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.486 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -71.85 -33.82 68.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.159 0.504 . . . . 0.0 110.885 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 4.4 pt-20 -67.43 -17.18 64.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.198 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.411 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 1.9 m120 -65.79 -38.48 89.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.896 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -116.42 -5.57 11.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.134 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.7 t -103.78 164.29 11.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 m120 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.587 -179.429 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.1 t -88.57 130.17 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -81.87 113.04 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -160.99 113.41 1.91 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.0 109.847 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' B' ' 6' ' ' LEU . 46.3 t-80 -59.97 156.4 14.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.007 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' B' ' 5' ' ' HIS . 48.7 tp -169.52 131.66 1.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.003 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 44.3 t -149.68 167.43 26.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.537 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.609 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -61.78 -43.52 99.12 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -59.78 -35.8 75.38 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.785 -0.244 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.79 -44.23 81.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -60.88 -39.5 89.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.528 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' B' ' 16' ' ' TYR . 55.6 t -62.67 -45.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.385 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.578 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.6 mt-10 -55.62 -34.46 64.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.03 81.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' B' ' 17' ' ' LEU . 86.6 mt -96.47 -9.0 30.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -50.92 -8.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.981 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' B' ' 15' ' ' LEU . 7.1 tt -60.93 -43.8 98.12 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.574 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.56 -16.43 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.11 0.481 . . . . 0.0 110.146 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 98.7 m -98.48 147.03 25.16 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.282 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.99 21.65 51.97 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' B' ' 23' ' ' GLY . 95.6 mt-10 -54.5 -44.45 72.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.541 0.21 . . . . 0.0 111.193 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 41.21 22.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 64.22 -128.9 37.04 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -110.85 20.85 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.459 ' CZ ' HG21 ' B' ' 27' ' ' THR . 36.0 t80 -57.13 114.87 2.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.513 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.75 112.23 18.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.347 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.459 HG21 ' CZ ' ' B' ' 25' ' ' PHE . 38.8 p -153.18 149.72 22.29 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.37 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -52.58 141.25 53.29 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 C-N-CA 121.581 1.521 . . . . 0.0 110.629 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -117.0 82.38 1.8 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.605 179.672 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 tp -106.85 -31.95 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.227 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 4' ' ' GLU . 18.3 m -63.16 -42.74 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 3' ' ' VAL . 47.1 tp10 -69.26 -30.49 68.63 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.122 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.6 -46.84 88.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.185 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 18.8 p -74.1 -54.5 7.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.13 0.49 . . . . 0.0 110.987 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 92.9 m -143.38 168.14 20.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.893 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.37 81.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.487 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -161.1 174.53 13.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.668 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t 62.15 42.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.154 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 t -148.29 117.19 6.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.424 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -115.7 156.47 25.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.522 0.677 . . . . 0.0 111.735 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -63.36 -27.13 69.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.413 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -58.44 -27.62 64.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -84.77 -23.38 29.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.814 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.44 -37.18 71.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.87 -8.9 58.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.653 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -49.28 -20.65 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.746 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CZ ' ' SG ' ' A' ' 20' ' ' CYS . 2.4 p90 -130.21 -3.14 4.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.288 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.606 ' SG ' ' CZ ' ' A' ' 19' ' ' TYR . 41.7 m -118.46 162.26 18.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.732 0.301 . . . . 0.0 110.399 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.429 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.17 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.01 110.32 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.411 . . . . 0.0 110.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -60.28 156.37 15.72 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 110.004 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -59.99 161.98 6.11 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.89 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -162.54 132.27 4.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.39 122.11 45.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.972 0.415 . . . . 0.0 110.302 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.455 ' C ' ' N ' ' B' ' 10' ' ' HIS . . . -78.51 -50.22 6.24 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.666 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.479 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 38.2 t -49.26 -15.47 0.13 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.096 0.448 . . . . 0.0 110.481 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.455 ' N ' ' C ' ' B' ' 8' ' ' GLY . 68.1 m-70 -101.51 -38.48 7.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.619 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -63.1 -39.47 94.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.319 179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -45.02 -63.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.983 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.68 ' H ' ' CD ' ' B' ' 13' ' ' GLU . 1.5 pm0 -66.48 -37.12 84.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.874 0.369 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.446 ' O ' HG12 ' B' ' 18' ' ' VAL . . . -68.56 -18.8 64.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' B' ' 11' ' ' LEU . 57.2 tp -62.2 -45.82 91.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.394 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 9.4 p90 -86.64 -34.65 19.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.961 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.03 -46.8 85.85 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.221 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.564 HG13 ' N ' ' B' ' 19' ' ' CYS . 7.7 p -69.54 -46.79 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.031 0 CA-C-O 120.614 0.245 . . . . 0.0 110.97 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.564 ' N ' HG13 ' B' ' 18' ' ' VAL . 6.5 m -136.18 169.98 16.76 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.007 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.35 20.07 72.87 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' B' ' 23' ' ' GLY . 96.0 mt-10 -62.76 -41.19 99.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.617 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 41.03 24.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 59.94 -126.23 41.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.693 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 68.7 t80 -111.66 19.05 18.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.803 0.335 . . . . 0.0 110.349 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -55.42 114.06 1.67 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.272 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -99.15 116.67 31.9 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.69 158.05 21.67 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.353 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.07 144.36 46.88 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -150.46 83.79 1.36 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.441 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 tp -105.27 -29.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 120.672 0.272 . . . . 0.0 111.45 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' CYS . 20.1 m -60.36 -30.65 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.54 -18.68 65.5 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.052 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.75 -48.2 72.68 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.501 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.511 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 10.8 p -85.69 -52.44 5.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -140.41 169.42 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.3 -53.1 31.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.018 0.437 . . . . 0.0 111.179 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -159.46 178.7 9.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.555 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.14 41.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.3 t -143.93 118.23 9.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.241 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -115.31 154.23 29.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.67 0.748 . . . . 0.0 111.539 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.7 mt -76.46 -15.02 60.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.72 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.511 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 3.0 m-85 -77.71 -34.02 52.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -26.12 20.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.648 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' A' ' 16' ' ' LEU . 19.8 mt -61.45 -28.03 68.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.147 0.498 . . . . 0.0 111.299 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 2.1 pt-20 -68.1 -16.3 63.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.915 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -57.64 -18.76 22.05 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -91.67 2.41 56.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.726 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 17' ' ' GLU . 2.0 t -157.09 149.43 23.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.591 0.234 . . . . 0.0 110.615 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.59 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.86 131.05 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.222 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -80.26 111.23 16.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.065 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -160.4 115.56 2.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.666 0.745 . . . . 0.0 109.887 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.51 163.14 16.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.64 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -167.27 139.35 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -108.84 139.59 43.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.124 0.488 . . . . 0.0 109.81 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 -49.55 6.22 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.554 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.457 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 6' ' ' CYS . 36.5 m-70 -73.57 -43.52 59.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.858 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.563 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -61.35 -40.23 93.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.63 -47.04 95.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 72.6 mm-40 -70.41 -38.84 74.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.62 -7.38 58.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.74 -39.06 79.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.143 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.7 m-85 -57.7 -47.84 81.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.39 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' B' ' 17' ' ' LEU . 3.4 mm? -63.59 -42.68 98.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.82 -46.1 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.649 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -154.96 159.25 40.25 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.264 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.42 ' O ' ' NH1' ' B' ' 22' ' ' ARG . . . 77.8 21.42 71.63 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.689 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' B' ' 17' ' ' LEU . 96.8 mt-10 -57.65 -36.33 71.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.867 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' B' ' 20' ' ' GLY . 93.0 mtm-85 48.44 35.18 5.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.035 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.79 -123.83 16.42 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.702 ' CD1' ' O ' ' B' ' 24' ' ' PHE . 0.5 OUTLIER -111.32 12.7 21.64 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -50.86 112.13 0.66 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.261 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.411 ' O ' HG23 ' B' ' 27' ' ' THR . 33.6 t80 -84.12 104.04 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.651 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.411 HG23 ' O ' ' B' ' 26' ' ' TYR . 32.2 p -155.66 83.7 3.56 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.473 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' B' ' 30' ' ' ALA . 6.0 Cg_exo -63.91 141.85 79.51 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.862 1.708 . . . . 0.0 112.017 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.466 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 11.3 pttm -55.41 80.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.298 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.622 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.42 -26.98 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 120.576 0.227 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -59.66 -26.38 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.09 0.471 . . . . 0.0 111.056 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.46 -24.05 64.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.786 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.75 -42.69 70.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -73.38 -52.09 15.03 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.726 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -142.02 -170.97 3.26 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.75 17.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 111.605 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 10' ' ' VAL . 30.4 t -151.04 -174.53 4.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.416 ' N ' ' OG ' ' A' ' 9' ' ' SER . 33.7 m 40.53 42.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.0 t -127.63 120.1 27.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 m -113.46 153.25 28.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.788 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.2 mm? -75.05 -41.39 59.14 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.61 -42.25 96.45 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' OE1' ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -61.91 -19.39 62.63 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.241 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.472 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 53.7 tp -81.39 -26.11 35.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.571 0.224 . . . . 0.0 111.372 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.13 -29.5 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 15' ' ' GLN . 12.4 p-10 -49.8 -21.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.601 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.475 ' CD2' ' C ' ' A' ' 19' ' ' TYR . 11.0 p90 -119.54 -15.8 8.96 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.36 162.92 15.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.79 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.534 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 72.5 t -91.66 130.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.29 105.14 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.658 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -162.42 121.04 2.2 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.019 0.824 . . . . 0.0 110.156 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -59.63 167.62 1.97 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.25 138.75 3.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.324 0.583 . . . . 0.0 110.898 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.35 131.0 55.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.572 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.14 -52.56 3.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.907 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -64.76 -14.34 58.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.205 0.526 . . . . 0.0 112.294 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -85.21 -37.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.04 -43.83 97.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.839 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.409 HG23 ' N ' ' B' ' 13' ' ' GLU . 5.1 m -69.98 -41.0 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.87 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.0 mt-10 -62.87 -47.11 84.76 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.88 69.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.13 -50.29 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.52 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 3.8 p90 -76.37 -23.13 54.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.88 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.507 HD13 ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -63.78 -49.82 71.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.767 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.73 -50.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.504 ' O ' ' O ' ' B' ' 16' ' ' TYR . 20.9 m -101.01 169.16 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.453 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.47 13.89 79.44 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.79 -38.83 87.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.733 0.302 . . . . 0.0 111.37 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 44.35 33.22 0.82 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.39 -134.78 45.12 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.613 ' CD2' ' N ' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -109.58 -13.45 14.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.893 0.346 . . . . 0.0 110.769 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -58.94 117.55 4.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.42 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -87.88 132.8 34.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.85 154.33 72.74 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.52 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -49.29 142.63 21.61 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.171 1.914 . . . . 0.0 111.835 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.39 83.61 2.05 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.379 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.616 -179.871 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 tp -107.31 -29.68 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.498 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.52 -48.99 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.185 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.72 -15.66 62.71 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -75.9 -42.13 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.664 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -75.62 -54.87 6.29 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.542 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 m -145.42 172.41 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.72 -39.72 71.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -173.41 178.66 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.91 41.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 109.742 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.2 t -129.36 116.82 19.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.222 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -114.91 128.89 56.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.798 0.808 . . . . 0.0 112.504 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.58 -50.31 14.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.693 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.62 -10.82 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.722 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' B' ' 16' ' ' TYR . 3.9 tp60 -72.57 -35.18 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.493 HD21 ' CG1' ' B' ' 12' ' ' VAL . 90.8 mt -62.03 -44.12 97.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.794 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.47 -35.48 73.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.162 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -45.54 -38.01 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.315 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.05 -57.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' LEU . 1.2 p -130.08 139.26 50.98 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.8 t30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.528 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.8 131.64 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.3 117.67 23.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 111.817 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.77 137.77 55.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.683 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.23 155.54 17.32 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.334 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -169.74 129.75 1.0 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.948 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.33 168.25 20.23 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.421 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -62.06 -32.73 83.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.934 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.513 ' OG ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 m -53.88 -26.28 24.09 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -74.27 -43.6 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.718 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.75 -33.91 76.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.493 ' CG1' HD21 ' A' ' 16' ' ' LEU . 69.4 t -60.74 -46.63 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.671 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.575 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 97.4 mt-10 -61.01 -59.14 5.85 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.0 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.55 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.1 -8.88 1.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.207 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 10.0 m-85 -49.14 -26.01 2.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.355 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.3 -41.8 98.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.446 0.641 . . . . 0.0 110.199 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.36 -40.83 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.912 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' B' ' 16' ' ' TYR . 73.6 m -91.67 169.91 10.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.491 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.85 19.48 73.48 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -36.75 81.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 42.28 28.56 0.11 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.689 0.28 . . . . 0.0 110.682 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.17 -130.16 48.69 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.14 3.38 35.77 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.617 -0.343 . . . . 0.0 110.788 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -88.92 114.95 26.09 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.932 0.872 . . . . 0.0 111.897 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -106.25 124.06 49.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.764 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.36 150.28 23.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.025 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.21 142.35 36.36 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.278 1.319 . . . . 0.0 110.893 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.48 82.04 4.87 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.159 0.504 . . . . 0.0 109.946 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.537 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 tp -106.94 -31.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.599 0.238 . . . . 0.0 110.969 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 4' ' ' GLU . 8.1 p -64.13 -37.86 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.044 0.45 . . . . 0.0 110.419 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 3' ' ' VAL . 83.7 tt0 -67.48 -25.33 65.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.719 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -64.34 -46.12 84.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.478 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 22.3 p -83.54 -52.53 6.4 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -142.34 169.96 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.06 -49.11 78.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 110.952 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -158.05 177.08 11.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.502 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 52.06 41.47 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.081 0.467 . . . . 0.0 111.75 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.85 117.69 14.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 110.319 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -115.93 157.93 23.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.521 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -63.2 -23.55 67.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.112 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -59.42 -27.93 66.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.609 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' OE1' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.11 -23.36 26.66 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.594 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 16' ' ' LEU . 10.9 mp -72.21 -34.37 68.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 7.1 pt-20 -67.85 -13.08 61.85 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.015 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 2.0 m120 -67.76 -22.96 65.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.818 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 74.0 m-85 -104.76 -13.66 15.82 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 72.4 m -155.07 172.71 17.68 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.661 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.468 ' O ' ' CG ' ' B' ' 1' ' ' PHE . 60.5 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.81 129.91 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.904 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.16 128.88 34.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.341 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -157.01 114.29 3.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 109.788 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -63.73 167.27 6.07 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 tp -154.44 129.64 9.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.083 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 37.5 t -151.34 169.39 22.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 111.048 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.647 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -63.91 -28.62 73.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m -50.48 -24.62 3.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -82.0 -39.94 22.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.044 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.571 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -62.94 -43.76 97.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.058 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 13' ' ' GLU . 33.0 m -68.4 -43.4 84.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.777 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 81.8 mt-10 -56.83 -29.01 62.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.03 -45.67 9.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.65 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.422 ' C ' ' N ' ' B' ' 17' ' ' LEU . 55.8 tp -64.8 -34.64 78.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.441 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -51.48 -11.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.025 -177.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' B' ' 16' ' ' TYR . 52.4 tp -62.79 -44.63 95.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.59 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.27 -45.84 14.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 121.271 0.558 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' B' ' 20' ' ' GLY . 42.2 t -97.79 163.83 12.64 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.925 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.492 ' N ' ' SG ' ' B' ' 19' ' ' CYS . . . 76.62 20.73 76.19 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.43 -44.41 87.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.332 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 45.31 36.84 2.46 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.662 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.92 -158.58 38.83 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.688 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 76.0 t80 -111.76 18.8 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.174 0.511 . . . . 0.0 110.084 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.35 113.11 1.28 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.238 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -90.26 128.06 36.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 5.8 p -150.12 151.65 32.25 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.312 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' B' ' 30' ' ' ALA . 3.3 Cg_exo -50.43 138.59 38.55 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.913 1.742 . . . . 0.0 111.305 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 9.8 pttm -54.87 81.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.7 0.762 . . . . 0.0 109.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.318 -0.782 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.578 ' O ' HD13 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -107.69 -35.49 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.873 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.7 p -60.4 -44.61 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.676 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' N ' HG13 ' A' ' 3' ' ' VAL . 42.6 tp10 -71.16 -32.52 69.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.119 0.485 . . . . 0.0 109.989 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' NE2' ' B' ' 10' ' ' HIS . 58.6 tt0 -62.48 -47.04 85.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.869 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -56.62 6.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.155 0.503 . . . . 0.0 110.184 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.98 168.57 20.56 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.648 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.47 -46.93 57.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.841 0.353 . . . . 0.0 111.717 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 p -161.25 172.27 16.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 67.06 41.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.842 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 t -138.9 118.05 12.63 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 t -115.07 167.3 10.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.559 0.695 . . . . 0.0 111.474 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.7 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.33 -31.99 71.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.027 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -59.53 -35.5 74.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -84.46 -22.74 30.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.277 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.61 -40.6 92.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.723 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -72.42 -10.05 59.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.457 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 19' ' ' TYR . 47.2 t30 -64.27 -35.44 80.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.433 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 18' ' ' ASN . 53.5 m-85 -108.22 -26.63 10.48 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 0.0 110.95 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.69 166.59 10.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.44 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.9 t30 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.431 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -71.04 128.71 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -89.55 106.11 18.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.219 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.0 117.0 2.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.673 0.749 . . . . 0.0 109.567 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -90.18 144.02 26.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.156 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -148.55 141.81 25.12 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.103 0.478 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -108.94 114.23 27.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.528 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.543 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -73.51 -53.25 7.62 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.66 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 65.3 m -58.69 -33.35 70.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.424 ' NE2' ' O ' ' A' ' 5' ' ' GLN . 46.1 t60 -78.71 -44.97 22.33 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.699 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.08 -42.33 98.31 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 8' ' ' GLY . 43.2 t -60.79 -46.44 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.983 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.53 ' O ' ' CE2' ' B' ' 16' ' ' TYR . 96.9 mt-10 -70.29 -37.86 74.89 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.201 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.4 -8.8 59.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.657 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.96 -46.03 92.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.509 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' B' ' 13' ' ' GLU . 24.4 p90 -79.67 -21.64 44.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.61 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.07 -47.37 74.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.05 -47.77 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.404 0.621 . . . . 0.0 110.263 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' B' ' 16' ' ' TYR . 1.1 m -103.91 155.02 18.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.124 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.21 19.43 72.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' B' ' 22' ' ' ARG . 97.6 mt-10 -56.83 -48.32 78.3 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 21' ' ' GLU . 85.7 mtp180 38.49 38.39 0.24 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.468 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.21 -119.87 12.47 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.713 ' CD2' ' O ' ' B' ' 24' ' ' PHE . 72.3 t80 -111.3 19.07 18.65 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.729 -0.277 . . . . 0.0 110.573 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.44 ' CE1' HG22 ' B' ' 27' ' ' THR . 30.2 t80 -54.18 112.33 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.678 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -94.42 132.06 39.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.624 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.44 HG22 ' CE1' ' B' ' 25' ' ' PHE . 1.4 p -139.81 158.44 67.73 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.098 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.64 143.75 82.14 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.274 1.983 . . . . 0.0 112.294 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -158.54 83.44 0.83 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.746 0.784 . . . . 0.0 110.027 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.8 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.651 -179.747 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 3' ' ' VAL . 12.7 pt -110.66 -29.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.587 0.232 . . . . 0.0 110.545 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.1 p -61.89 -43.52 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.484 ' N ' HG13 ' A' ' 3' ' ' VAL . 80.5 tt0 -69.7 -31.17 69.05 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.516 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -63.09 -43.94 97.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.374 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.28 -58.53 4.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.734 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 59.4 m -150.86 167.84 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.92 -15.82 59.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.516 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.476 ' C ' HG22 ' A' ' 10' ' ' VAL . 15.3 t -170.64 -171.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG22 ' C ' ' A' ' 9' ' ' SER . 21.3 m 41.93 40.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.821 0.343 . . . . 0.0 111.788 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.3 t -154.17 115.08 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.103 0.477 . . . . 0.0 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -118.11 147.23 43.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.24 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 -30.93 71.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.317 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.554 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 65.7 m-85 -58.63 -8.15 1.18 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.236 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' NE2' ' CG ' ' A' ' 18' ' ' ASN . 10.9 tp60 -80.86 -24.83 38.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.4 tp -71.0 -35.0 71.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.915 -0.491 . . . . 0.0 111.179 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.2 pt-20 -67.9 -16.31 64.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.922 HD22 ' H ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -62.57 -37.92 88.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -109.68 -34.88 6.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.565 0.621 . . . . 0.0 112.1 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 CA--C 1.531 0.242 0 O-C-N 121.876 -0.515 . . . . 0.0 110.608 -179.59 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.21 134.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -86.87 104.61 16.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.01 119.47 2.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.456 0.646 . . . . 0.0 109.511 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -80.16 128.7 33.82 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.422 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -135.48 132.43 37.34 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.666 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 10.4 t -153.43 -175.68 5.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.286 0.565 . . . . 0.0 111.053 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -60.43 -34.9 87.25 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -58.96 -36.19 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.063 0.459 . . . . 0.0 110.135 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -68.36 -41.05 81.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.96 -39.5 90.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.326 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 8' ' ' GLY . 54.8 t -64.59 -42.88 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.896 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.568 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 94.6 mt-10 -64.23 -43.84 93.69 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.359 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.97 -10.42 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' B' ' 13' ' ' GLU . 3.6 mm? -61.72 -27.12 68.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 6.1 p90 -48.8 -20.65 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.302 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.91 -50.27 71.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.556 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -92.1 -28.33 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 121.002 0.43 . . . . 0.0 110.746 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.223 -0.315 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.145 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tt -106.48 -28.08 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.976 0.417 . . . . 0.0 110.812 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.48 -23.77 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.19 -8.32 52.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -39.65 -62.92 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -54.27 3.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.069 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.94 167.97 20.81 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.79 86.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.811 0.815 . . . . 0.0 109.896 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.69 ' O ' HG22 ' A' ' 10' ' ' VAL . 28.4 t -138.3 -175.29 4.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.852 HG21 ' CE1' ' B' ' 10' ' ' HIS . 0.7 OUTLIER 60.24 19.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 123.449 0.468 . . . . 0.0 111.158 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.57 115.21 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.339 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.6 m -119.71 151.17 39.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.704 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -69.11 -40.55 78.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.312 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 67.2 m-85 -62.12 -32.05 72.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.546 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.66 -22.89 25.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.437 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -68.35 -37.83 80.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.539 0.685 . . . . 0.0 110.538 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.7 pt-20 -66.68 -15.78 63.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.529 -177.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.829 ' H ' HD22 ' A' ' 18' ' ' ASN . 0.5 OUTLIER -66.16 -32.11 73.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -107.02 -43.43 4.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.695 0.284 . . . . 0.0 110.51 179.706 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.35 126.21 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -92.99 121.42 34.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.117 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -161.13 118.64 2.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -59.18 178.3 0.14 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.22 172.85 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.895 0.855 . . . . 0.0 112.978 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 163.0 38.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.885 -1.507 . . . . 0.0 106.991 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' B' ' 10' ' ' HIS . . . -65.34 -45.77 89.31 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.202 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -65.75 5.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.287 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.852 ' CE1' HG21 ' A' ' 10' ' ' VAL . 16.4 t60 -63.56 -42.85 98.34 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.08 -38.54 82.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.406 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.03 -40.64 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.942 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 91.0 mt-10 -44.61 -37.95 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.226 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 -8.44 1.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.594 ' O ' HD13 ' B' ' 15' ' ' LEU . 0.2 OUTLIER -61.77 -39.61 92.26 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.253 -178.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.8 m-85 -48.54 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.265 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' B' ' 15' ' ' LEU . 85.8 mt -62.52 -39.25 92.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.789 0.328 . . . . 0.0 110.557 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.57 HG13 ' N ' ' B' ' 19' ' ' CYS . 7.4 p -57.3 -45.23 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 110.262 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.57 ' N ' HG13 ' B' ' 18' ' ' VAL . 1.1 p . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.773 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tt -106.46 -26.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.14 -31.96 49.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -83.17 -8.56 59.47 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -40.14 -39.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.977 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.69 -50.72 10.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.124 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -140.49 173.07 11.86 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.88 79.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -156.39 178.73 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 54.89 40.93 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.617 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -152.42 119.21 5.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.532 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -114.61 147.08 40.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 111.398 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.25 -38.26 89.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.786 0.803 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -59.31 -38.85 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.702 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -83.36 -20.72 33.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.294 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.04 -39.87 90.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.445 0.641 . . . . 0.0 111.025 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.32 -8.49 56.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.738 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 18' ' ' ASN . 0.0 OUTLIER -46.79 -20.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.54 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.514 ' CE2' ' SG ' ' A' ' 20' ' ' CYS . 7.0 p90 -123.17 -11.01 8.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' CE2' ' A' ' 19' ' ' TYR . 1.6 m . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.766 0.317 . . . . 0.0 110.489 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.49 132.26 33.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.128 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -85.46 104.68 15.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.562 ' NE2' ' ND1' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.25 116.88 2.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.798 0.809 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.562 ' ND1' ' NE2' ' B' ' 4' ' ' GLN . 0.0 OUTLIER -73.93 118.21 16.63 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.073 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 33.6 mt -149.37 131.98 15.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.303 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -151.82 -178.42 6.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -70.76 -14.46 72.81 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -65.75 -18.63 65.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 0.0 110.304 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -70.02 -41.32 74.44 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.93 -45.74 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.445 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 87.4 mt-10 -52.66 -25.29 10.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.39 -49.48 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.928 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.98 -39.84 95.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.456 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 0.1 OUTLIER -49.15 -22.32 0.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.644 -178.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 8.1 tt -63.73 -46.59 84.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.547 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.35 -34.88 71.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.298 0.571 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' B' ' 16' ' ' TYR . 37.2 t . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.423 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tt -106.27 -28.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.745 0.307 . . . . 0.0 110.953 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 4' ' ' GLU . 13.6 m -62.94 -38.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.999 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.431 ' N ' HG23 ' A' ' 3' ' ' VAL . 97.5 mt-10 -65.07 -32.86 74.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.06 0.457 . . . . 0.0 110.107 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -65.91 -45.65 81.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.23 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -53.19 52.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 12.9 t -144.25 -171.23 3.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.48 -46.56 73.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p 178.94 -179.72 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.416 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t 60.98 41.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.302 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 8.1 p -158.0 118.25 3.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -116.64 148.01 41.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.013 0.435 . . . . 0.0 111.544 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.8 -37.51 82.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.695 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -59.95 -9.28 2.88 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.923 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.562 HE21 ' CA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -87.6 -21.39 25.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.486 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -71.85 -33.82 68.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.159 0.504 . . . . 0.0 110.885 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 4.4 pt-20 -67.43 -17.18 64.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.198 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.865 ' H ' HD22 ' A' ' 18' ' ' ASN . 0.5 OUTLIER -65.79 -38.48 89.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.896 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -116.42 -5.57 11.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.134 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.328 -0.353 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.702 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.1 t -88.57 130.17 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -81.87 113.04 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -160.99 113.41 1.91 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.0 109.847 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' B' ' 6' ' ' LEU . 46.3 t-80 -59.97 156.4 14.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.007 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' B' ' 5' ' ' HIS . 48.7 tp -169.52 131.66 1.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.003 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 44.3 t -149.68 167.43 26.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.537 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.609 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -61.78 -43.52 99.12 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -59.78 -35.8 75.38 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.785 -0.244 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.79 -44.23 81.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -60.88 -39.5 89.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.528 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' B' ' 16' ' ' TYR . 55.6 t -62.67 -45.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.385 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.578 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.6 mt-10 -55.62 -34.46 64.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.03 81.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' B' ' 17' ' ' LEU . 86.6 mt -96.47 -9.0 30.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -50.92 -8.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.981 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' B' ' 15' ' ' LEU . 7.1 tt -60.93 -43.8 98.12 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.574 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.56 -16.43 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.11 0.481 . . . . 0.0 110.146 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 98.7 m . . . . . 0 N--CA 1.465 0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.282 179.747 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 tp -106.85 -31.95 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.227 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 4' ' ' GLU . 18.3 m -63.16 -42.74 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 3' ' ' VAL . 47.1 tp10 -69.26 -30.49 68.63 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.122 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.6 -46.84 88.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.185 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 18.8 p -74.1 -54.5 7.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.13 0.49 . . . . 0.0 110.987 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 92.9 m -143.38 168.14 20.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.893 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.37 81.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.487 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -161.1 174.53 13.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.668 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t 62.15 42.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.154 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 t -148.29 117.19 6.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.424 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -115.7 156.47 25.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.522 0.677 . . . . 0.0 111.735 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -63.36 -27.13 69.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.413 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -58.44 -27.62 64.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -84.77 -23.38 29.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.814 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.44 -37.18 71.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.87 -8.9 58.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.653 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -20.65 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.746 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CZ ' ' SG ' ' A' ' 20' ' ' CYS . 2.4 p90 -130.21 -3.14 4.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.288 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.606 ' SG ' ' CZ ' ' A' ' 19' ' ' TYR . 41.7 m . . . . . 0 C--N 1.332 -0.155 0 CA-C-O 120.732 0.301 . . . . 0.0 110.399 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.17 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.01 110.32 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.411 . . . . 0.0 110.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -60.28 156.37 15.72 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 110.004 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -59.99 161.98 6.11 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.89 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -162.54 132.27 4.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.39 122.11 45.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.972 0.415 . . . . 0.0 110.302 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.455 ' C ' ' N ' ' B' ' 10' ' ' HIS . . . -78.51 -50.22 6.24 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.666 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.479 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 38.2 t -49.26 -15.47 0.13 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.096 0.448 . . . . 0.0 110.481 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.455 ' N ' ' C ' ' B' ' 8' ' ' GLY . 68.1 m-70 -101.51 -38.48 7.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.619 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -63.1 -39.47 94.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.319 179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -45.02 -63.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.983 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.68 ' H ' ' CD ' ' B' ' 13' ' ' GLU . 1.5 pm0 -66.48 -37.12 84.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.874 0.369 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.446 ' O ' HG12 ' B' ' 18' ' ' VAL . . . -68.56 -18.8 64.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' B' ' 11' ' ' LEU . 57.2 tp -62.2 -45.82 91.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.394 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 9.4 p90 -86.64 -34.65 19.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.961 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.03 -46.8 85.85 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.221 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.564 HG13 ' N ' ' B' ' 19' ' ' CYS . 7.7 p -69.54 -46.79 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.031 0 CA-C-O 120.614 0.245 . . . . 0.0 110.97 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.564 ' N ' HG13 ' B' ' 18' ' ' VAL . 6.5 m . . . . . 0 C--O 1.226 -0.183 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 tp -105.27 -29.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 120.672 0.272 . . . . 0.0 111.45 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' CYS . 20.1 m -60.36 -30.65 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.54 -18.68 65.5 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.052 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.75 -48.2 72.68 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.501 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.511 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 10.8 p -85.69 -52.44 5.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -140.41 169.42 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.3 -53.1 31.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.018 0.437 . . . . 0.0 111.179 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -159.46 178.7 9.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.555 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.14 41.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.3 t -143.93 118.23 9.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.241 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -115.31 154.23 29.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.67 0.748 . . . . 0.0 111.539 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.7 mt -76.46 -15.02 60.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.72 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.511 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 3.0 m-85 -77.71 -34.02 52.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.817 ' C ' HE21 ' A' ' 15' ' ' GLN . 0.0 OUTLIER -89.71 -26.12 20.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.648 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.639 ' N ' HE21 ' A' ' 15' ' ' GLN . 19.8 mt -61.45 -28.03 68.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.147 0.498 . . . . 0.0 111.299 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 2.1 pt-20 -68.1 -16.3 63.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.915 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.547 ' ND2' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -57.64 -18.76 22.05 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.547 ' CD1' ' ND2' ' A' ' 18' ' ' ASN . 65.9 m-85 -91.67 2.41 56.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.726 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 17' ' ' GLU . 2.0 t . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.591 0.234 . . . . 0.0 110.615 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.86 131.05 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.222 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.633 HD22 ' N ' ' B' ' 3' ' ' ASN . 1.2 m120 -80.26 111.23 16.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.065 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -160.4 115.56 2.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.666 0.745 . . . . 0.0 109.887 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.51 163.14 16.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.64 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -167.27 139.35 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -108.84 139.59 43.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.124 0.488 . . . . 0.0 109.81 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 -49.55 6.22 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.554 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.457 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 6' ' ' CYS . 36.5 m-70 -73.57 -43.52 59.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.858 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.563 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -61.35 -40.23 93.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.63 -47.04 95.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 72.6 mm-40 -70.41 -38.84 74.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.62 -7.38 58.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.74 -39.06 79.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.143 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.7 m-85 -57.7 -47.84 81.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.39 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' B' ' 17' ' ' LEU . 3.4 mm? -63.59 -42.68 98.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.82 -46.1 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.649 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.264 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.42 -26.98 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 120.576 0.227 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -59.66 -26.38 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.09 0.471 . . . . 0.0 111.056 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.46 -24.05 64.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.786 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.75 -42.69 70.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -73.38 -52.09 15.03 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.726 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -142.02 -170.97 3.26 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.75 17.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 111.605 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 10' ' ' VAL . 30.4 t -151.04 -174.53 4.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.416 ' N ' ' OG ' ' A' ' 9' ' ' SER . 33.7 m 40.53 42.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.0 t -127.63 120.1 27.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 m -113.46 153.25 28.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.788 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.2 mm? -75.05 -41.39 59.14 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.61 -42.25 96.45 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.775 HE21 ' N ' ' A' ' 16' ' ' LEU . 1.5 pp0? -61.91 -19.39 62.63 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.241 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.775 ' N ' HE21 ' A' ' 15' ' ' GLN . 53.7 tp -81.39 -26.11 35.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.571 0.224 . . . . 0.0 111.372 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.13 -29.5 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -49.8 -21.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.601 -178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.475 ' C ' ' CD2' ' A' ' 19' ' ' TYR . 11.0 p90 -119.54 -15.8 8.96 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.79 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 72.5 t -91.66 130.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.29 105.14 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.658 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -162.42 121.04 2.2 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.019 0.824 . . . . 0.0 110.156 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -59.63 167.62 1.97 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.25 138.75 3.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.324 0.583 . . . . 0.0 110.898 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.35 131.0 55.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.572 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.14 -52.56 3.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.907 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -64.76 -14.34 58.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.205 0.526 . . . . 0.0 112.294 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -85.21 -37.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.04 -43.83 97.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.839 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.409 HG23 ' N ' ' B' ' 13' ' ' GLU . 5.1 m -69.98 -41.0 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.87 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.0 mt-10 -62.87 -47.11 84.76 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.88 69.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.13 -50.29 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.52 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 3.8 p90 -76.37 -23.13 54.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.88 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.507 ' O ' HD13 ' B' ' 17' ' ' LEU . 0.2 OUTLIER -63.78 -49.82 71.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.767 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.73 -50.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.504 ' O ' ' O ' ' B' ' 16' ' ' TYR . 20.9 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.453 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 tp -107.31 -29.68 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.498 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.52 -48.99 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.185 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.72 -15.66 62.71 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -75.9 -42.13 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.664 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -75.62 -54.87 6.29 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.542 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 m -145.42 172.41 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.72 -39.72 71.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -173.41 178.66 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.91 41.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 109.742 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.2 t -129.36 116.82 19.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.222 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -114.91 128.89 56.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.798 0.808 . . . . 0.0 112.504 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.58 -50.31 14.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.693 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.62 -10.82 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.722 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' B' ' 16' ' ' TYR . 3.9 tp60 -72.57 -35.18 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.493 HD21 ' CG1' ' B' ' 12' ' ' VAL . 90.8 mt -62.03 -44.12 97.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.794 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.47 -35.48 73.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.162 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -45.54 -38.01 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.315 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.05 -57.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' LEU . 1.2 p . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.8 131.64 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.3 117.67 23.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 111.817 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.77 137.77 55.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.683 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.23 155.54 17.32 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.334 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -169.74 129.75 1.0 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.948 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.33 168.25 20.23 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.421 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -62.06 -32.73 83.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.934 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.513 ' OG ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 m -53.88 -26.28 24.09 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -74.27 -43.6 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.718 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.75 -33.91 76.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.493 ' CG1' HD21 ' A' ' 16' ' ' LEU . 69.4 t -60.74 -46.63 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.671 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.575 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 97.4 mt-10 -61.01 -59.14 5.85 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.0 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.55 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.1 -8.88 1.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.207 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 10.0 m-85 -49.14 -26.01 2.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.355 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.3 -41.8 98.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.446 0.641 . . . . 0.0 110.199 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.36 -40.83 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.912 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' B' ' 16' ' ' TYR . 73.6 m . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.491 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 tp -106.94 -31.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.599 0.238 . . . . 0.0 110.969 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 4' ' ' GLU . 8.1 p -64.13 -37.86 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.044 0.45 . . . . 0.0 110.419 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 3' ' ' VAL . 83.7 tt0 -67.48 -25.33 65.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.719 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -64.34 -46.12 84.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.478 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 22.3 p -83.54 -52.53 6.4 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -142.34 169.96 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.06 -49.11 78.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 110.952 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -158.05 177.08 11.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.502 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 52.06 41.47 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.081 0.467 . . . . 0.0 111.75 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.85 117.69 14.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 110.319 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -115.93 157.93 23.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.521 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -63.2 -23.55 67.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.112 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.513 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 64.8 m-85 -59.42 -27.93 66.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.609 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.564 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.11 -23.36 26.66 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.594 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 16' ' ' LEU . 10.9 mp -72.21 -34.37 68.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 7.1 pt-20 -67.85 -13.08 61.85 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.015 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.805 ' H ' HD22 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -67.76 -22.96 65.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.818 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 74.0 m-85 -104.76 -13.66 15.82 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 72.4 m . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.908 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' B' ' 1' ' ' PHE . 60.5 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.81 129.91 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.904 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.16 128.88 34.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.341 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -157.01 114.29 3.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 109.788 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -63.73 167.27 6.07 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 tp -154.44 129.64 9.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.083 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 37.5 t -151.34 169.39 22.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 111.048 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.647 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -63.91 -28.62 73.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m -50.48 -24.62 3.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -82.0 -39.94 22.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.044 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.571 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -62.94 -43.76 97.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.058 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 13' ' ' GLU . 33.0 m -68.4 -43.4 84.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.777 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 81.8 mt-10 -56.83 -29.01 62.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.03 -45.67 9.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.65 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.422 ' C ' ' N ' ' B' ' 17' ' ' LEU . 55.8 tp -64.8 -34.64 78.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.441 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -51.48 -11.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.025 -177.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' B' ' 16' ' ' TYR . 52.4 tp -62.79 -44.63 95.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.59 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.27 -45.84 14.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 121.271 0.558 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' B' ' 16' ' ' TYR . 42.2 t . . . . . 0 C--O 1.224 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.925 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.578 ' O ' HD13 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -107.69 -35.49 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.873 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.7 p -60.4 -44.61 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.676 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' N ' HG13 ' A' ' 3' ' ' VAL . 42.6 tp10 -71.16 -32.52 69.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.119 0.485 . . . . 0.0 109.989 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' NE2' ' B' ' 10' ' ' HIS . 58.6 tt0 -62.48 -47.04 85.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.869 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -56.62 6.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.155 0.503 . . . . 0.0 110.184 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.98 168.57 20.56 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.648 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.47 -46.93 57.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.841 0.353 . . . . 0.0 111.717 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 p -161.25 172.27 16.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 67.06 41.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.842 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 t -138.9 118.05 12.63 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 t -115.07 167.3 10.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.559 0.695 . . . . 0.0 111.474 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.7 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.33 -31.99 71.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.027 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -59.53 -35.5 74.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.46 -22.74 30.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.277 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.61 -40.6 92.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.723 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -72.42 -10.05 59.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.457 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 19' ' ' TYR . 47.2 t30 -64.27 -35.44 80.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.433 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 18' ' ' ASN . 53.5 m-85 -108.22 -26.63 10.48 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 0.0 110.95 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.531 0.215 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.44 -179.84 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -71.04 128.71 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -89.55 106.11 18.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.219 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.0 117.0 2.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.673 0.749 . . . . 0.0 109.567 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' HIS . . . . . 0.46 ' O ' ' NE2' ' B' ' 4' ' ' GLN . 68.9 t60 -90.18 144.02 26.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.156 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -148.55 141.81 25.12 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.103 0.478 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -108.94 114.23 27.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.528 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.543 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -73.51 -53.25 7.62 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.66 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 65.3 m -58.69 -33.35 70.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' HIS . . . . . 0.424 ' NE2' ' O ' ' A' ' 5' ' ' GLN . 46.1 t60 -78.71 -44.97 22.33 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.699 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.08 -42.33 98.31 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 8' ' ' GLY . 43.2 t -60.79 -46.44 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.983 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.53 ' O ' ' CE2' ' B' ' 16' ' ' TYR . 96.9 mt-10 -70.29 -37.86 74.89 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.201 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.4 -8.8 59.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.657 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.96 -46.03 92.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.509 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' B' ' 13' ' ' GLU . 24.4 p90 -79.67 -21.64 44.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.61 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.07 -47.37 74.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.05 -47.77 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.404 0.621 . . . . 0.0 110.263 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' B' ' 16' ' ' TYR . 1.1 m . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.124 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 3' ' ' VAL . 12.7 pt -110.66 -29.0 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.587 0.232 . . . . 0.0 110.545 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.1 p -61.89 -43.52 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.484 ' N ' HG13 ' A' ' 3' ' ' VAL . 80.5 tt0 -69.7 -31.17 69.05 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.516 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -63.09 -43.94 97.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.374 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -68.28 -58.53 4.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.734 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' SG ' ' A' ' 6' ' ' CYS . 59.4 m -150.86 167.84 26.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.92 -15.82 59.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.516 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.476 ' C ' HG22 ' A' ' 10' ' ' VAL . 15.3 t -170.64 -171.08 0.99 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG22 ' C ' ' A' ' 9' ' ' SER . 21.3 m 41.93 40.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.821 0.343 . . . . 0.0 111.788 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.3 t -154.17 115.08 4.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.103 0.477 . . . . 0.0 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 90.4 p -118.11 147.23 43.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.24 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.99 -30.93 71.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.317 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.554 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 65.7 m-85 -58.63 -8.15 1.18 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.236 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' NE2' ' CG ' ' A' ' 18' ' ' ASN . 10.9 tp60 -80.86 -24.83 38.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.4 tp -71.0 -35.0 71.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.915 -0.491 . . . . 0.0 111.179 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.2 pt-20 -67.9 -16.31 64.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.922 ' H ' HD22 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -62.57 -37.92 88.06 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -109.68 -34.88 6.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.565 0.621 . . . . 0.0 112.1 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.5 m -101.8 160.64 14.3 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.876 -0.515 . . . . 0.0 110.608 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.567 -179.469 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.21 134.5 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -86.87 104.61 16.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.799 0.333 . . . . 0.0 111.365 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.01 119.47 2.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.456 0.646 . . . . 0.0 109.511 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 15.2 t-160 -80.16 128.7 33.82 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.058 -0.973 . . . . 0.0 111.422 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -135.48 132.43 37.34 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.666 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 10.4 t -153.43 -175.68 5.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.286 0.565 . . . . 0.0 111.053 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -60.43 -34.9 87.25 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -58.96 -36.19 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.063 0.459 . . . . 0.0 110.135 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -68.36 -41.05 81.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -65.96 -39.5 90.48 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.326 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 8' ' ' GLY . 54.8 t -64.59 -42.88 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.896 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.568 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 94.6 mt-10 -64.23 -43.84 93.69 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.359 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.97 -10.42 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' B' ' 13' ' ' GLU . 3.6 mm? -61.72 -27.12 68.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 6.1 p90 -48.8 -20.65 0.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.302 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.91 -50.27 71.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.556 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 t -92.1 -28.33 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 121.002 0.43 . . . . 0.0 110.746 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 23.5 m -95.07 168.26 10.87 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.145 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.497 ' O ' ' NH1' ' B' ' 22' ' ' ARG . . . 77.8 17.44 78.68 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 23' ' ' GLY . 81.0 mm-40 -70.57 -47.94 57.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.868 0.366 . . . . 0.0 110.472 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' B' ' 20' ' ' GLY . 91.5 mtm-85 42.35 20.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.604 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 63.22 -125.05 33.39 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -96.25 -7.13 36.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.655 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.77 117.46 12.32 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.304 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -98.59 132.53 43.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.68 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.43 150.33 28.63 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.536 ' O ' ' N ' ' B' ' 30' ' ' ALA . 4.2 Cg_exo -50.58 139.47 38.37 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.421 1.414 . . . . 0.0 112.047 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' B' ' 29' ' ' LYS . 23.7 pttt -54.98 81.34 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.78 0.8 . . . . 0.0 110.293 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.748 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tt -106.48 -28.08 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 120.976 0.417 . . . . 0.0 110.812 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.0 t -60.48 -23.77 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.19 -8.32 52.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.963 0.411 . . . . 0.0 110.497 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -39.65 -62.92 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -91.35 -54.27 3.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.069 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.94 167.97 20.81 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.79 86.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.811 0.815 . . . . 0.0 109.896 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.69 ' O ' HG22 ' A' ' 10' ' ' VAL . 28.4 t -138.3 -175.29 4.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.852 HG21 ' CE1' ' B' ' 10' ' ' HIS . 0.7 OUTLIER 60.24 19.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 123.449 0.468 . . . . 0.0 111.158 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.57 115.21 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.339 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.6 m -119.71 151.17 39.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.704 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -69.11 -40.55 78.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.312 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 67.2 m-85 -62.12 -32.05 72.58 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.546 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.66 -22.89 25.87 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 110.437 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -68.35 -37.83 80.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.539 0.685 . . . . 0.0 110.538 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 7.7 pt-20 -66.68 -15.78 63.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.529 -177.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.829 ' H ' HD22 ' A' ' 18' ' ' ASN . 0.5 OUTLIER -66.16 -32.11 73.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -107.02 -43.43 4.64 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -158.69 168.15 27.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.695 0.284 . . . . 0.0 110.51 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.416 179.849 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.35 126.21 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -92.99 121.42 34.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.117 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -161.13 118.64 2.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -59.18 178.3 0.14 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.229 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -171.22 172.85 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.895 0.855 . . . . 0.0 112.978 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 163.0 38.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.885 -1.507 . . . . 0.0 106.991 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' B' ' 10' ' ' HIS . . . -65.34 -45.77 89.31 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 119.08 -1.533 . . . . 0.0 110.202 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 33.5 t -65.75 5.16 0.49 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.287 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.852 ' CE1' HG21 ' A' ' 10' ' ' VAL . 16.4 t60 -63.56 -42.85 98.34 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -68.08 -38.54 82.5 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.406 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.4 t -59.03 -40.64 81.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.942 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.584 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 91.0 mt-10 -44.61 -37.95 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.226 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.22 -8.44 1.11 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.594 ' O ' HD13 ' B' ' 15' ' ' LEU . 0.2 OUTLIER -61.77 -39.61 92.26 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.253 -178.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.8 m-85 -48.54 -11.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.265 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' B' ' 15' ' ' LEU . 85.8 mt -62.52 -39.25 92.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.789 0.328 . . . . 0.0 110.557 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.57 HG13 ' N ' ' B' ' 19' ' ' CYS . 7.4 p -57.3 -45.23 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 110.262 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.57 ' N ' HG13 ' B' ' 18' ' ' VAL . 1.1 p -95.53 169.06 10.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.773 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.42 -3.07 85.33 Favored Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' B' ' 23' ' ' GLY . 96.7 mt-10 -65.81 -37.47 86.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.564 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' B' ' 21' ' ' GLU . 16.5 ptm180 35.7 30.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.104 0.478 . . . . 0.0 110.884 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 67.91 -172.32 33.29 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.642 ' N ' ' CD2' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -97.57 -5.81 34.85 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.902 -0.175 . . . . 0.0 110.53 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.06 118.21 5.58 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.797 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.61 136.2 33.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.872 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -155.77 81.52 3.85 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -50.94 139.09 42.0 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.403 2.069 . . . . 0.0 112.076 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -96.96 81.88 3.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.814 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.557 179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tt -106.46 -26.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -60.14 -31.96 49.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -83.17 -8.56 59.47 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -40.14 -39.73 0.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.977 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.69 -50.72 10.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.124 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.518 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -140.49 173.07 11.86 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.6 -48.88 79.46 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -156.39 178.73 9.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 54.89 40.93 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.617 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -152.42 119.21 5.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.532 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -114.61 147.08 40.05 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.172 0.51 . . . . 0.0 111.398 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.9 mt -65.25 -38.26 89.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.786 0.803 . . . . 0.0 109.215 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -59.31 -38.85 81.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.702 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -83.36 -20.72 33.76 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.294 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.04 -39.87 90.53 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.445 0.641 . . . . 0.0 111.025 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -74.32 -8.49 56.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.738 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 18' ' ' ASN . 0.0 OUTLIER -46.79 -20.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.54 -179.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.514 ' CE2' ' SG ' ' A' ' 20' ' ' CYS . 7.0 p90 -123.17 -11.01 8.05 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.653 0.263 . . . . 0.0 111.367 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' N ' ' B' ' 20' ' ' GLY . 1.6 m -140.97 160.55 39.84 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.766 0.317 . . . . 0.0 110.489 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 C--O 1.219 -0.527 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.586 -179.728 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.49 132.26 33.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.128 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -85.46 104.68 15.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.562 ' NE2' ' ND1' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.25 116.88 2.13 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.798 0.809 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.562 ' ND1' ' NE2' ' B' ' 4' ' ' GLN . 0.0 OUTLIER -73.93 118.21 16.63 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.073 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 33.6 mt -149.37 131.98 15.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.303 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 t -151.82 -178.42 6.72 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.51 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 7' ' ' CYS . . . -70.76 -14.46 72.81 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -65.75 -18.63 65.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.961 0.41 . . . . 0.0 110.304 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -70.02 -41.32 74.44 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.68 -38.75 92.07 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.93 -45.74 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.445 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.541 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 87.4 mt-10 -52.66 -25.29 10.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.39 -49.48 6.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.928 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.98 -39.84 95.93 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.456 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' B' ' 17' ' ' LEU . 0.1 OUTLIER -49.15 -22.32 0.95 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.644 -178.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' B' ' 16' ' ' TYR . 8.1 tt -63.73 -46.59 84.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.547 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 2.2 p -67.35 -34.88 71.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.298 0.571 . . . . 0.0 110.524 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' B' ' 16' ' ' TYR . 37.2 t -94.48 168.72 10.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.423 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.596 ' N ' ' SG ' ' A' ' 20' ' ' CYS . . . 83.77 10.66 80.88 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -67.64 -36.4 80.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.777 0.322 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 48.59 27.08 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.31 -127.6 8.0 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.614 ' O ' ' CG ' ' B' ' 24' ' ' PHE . 6.7 t80 -111.87 -3.54 14.85 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.247 0.546 . . . . 0.0 109.659 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -52.89 109.01 0.37 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 118.58 -1.248 . . . . 0.0 110.031 -176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -96.24 126.94 41.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.992 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 2.0 p -147.34 153.94 44.94 Favored Pre-proline 0 N--CA 1.466 0.346 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.549 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -47.82 137.15 21.93 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 122.032 1.822 . . . . 0.0 110.985 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -142.18 84.23 1.87 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.186 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tt -106.27 -28.16 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.745 0.307 . . . . 0.0 110.953 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 4' ' ' GLU . 13.6 m -62.94 -38.8 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.999 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.431 ' N ' HG23 ' A' ' 3' ' ' VAL . 97.5 mt-10 -65.07 -32.86 74.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.06 0.457 . . . . 0.0 110.107 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -65.91 -45.65 81.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.23 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -53.19 52.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 12.9 t -144.25 -171.23 3.53 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.48 -46.56 73.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 p 178.94 -179.72 0.37 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.416 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t 60.98 41.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.302 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 8.1 p -158.0 118.25 3.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -116.64 148.01 41.38 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.013 0.435 . . . . 0.0 111.544 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.8 -37.51 82.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.695 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -59.95 -9.28 2.88 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.923 -179.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.562 HE21 ' CA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -87.6 -21.39 25.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.486 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 48.5 mt -71.85 -33.82 68.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.159 0.504 . . . . 0.0 110.885 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 4.4 pt-20 -67.43 -17.18 64.61 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.198 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.865 ' H ' HD22 ' A' ' 18' ' ' ASN . 0.5 OUTLIER -65.79 -38.48 89.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.896 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -116.42 -5.57 11.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.134 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.7 t -103.78 164.29 11.78 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.0 m120 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.587 -179.429 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 75.1 t -88.57 130.17 38.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.048 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -81.87 113.04 19.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.664 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -160.99 113.41 1.91 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.0 109.847 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' B' ' 6' ' ' LEU . 46.3 t-80 -59.97 156.4 14.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.007 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' B' ' 5' ' ' HIS . 48.7 tp -169.52 131.66 1.16 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.003 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 44.3 t -149.68 167.43 26.44 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.537 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.609 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -61.78 -43.52 99.12 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 20.1 m -59.78 -35.8 75.38 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 122.785 -0.244 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.79 -44.23 81.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -60.88 -39.5 89.46 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.528 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' B' ' 16' ' ' TYR . 55.6 t -62.67 -45.28 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.385 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.578 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.6 mt-10 -55.62 -34.46 64.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.71 -43.03 81.02 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' B' ' 17' ' ' LEU . 86.6 mt -96.47 -9.0 30.69 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -50.92 -8.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.981 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' B' ' 15' ' ' LEU . 7.1 tt -60.93 -43.8 98.12 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.574 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 98.6 t -67.56 -16.43 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.11 0.481 . . . . 0.0 110.146 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 98.7 m -98.48 147.03 25.16 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.282 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.99 21.65 51.97 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' B' ' 23' ' ' GLY . 95.6 mt-10 -54.5 -44.45 72.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.541 0.21 . . . . 0.0 111.193 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 41.21 22.52 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.804 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 64.22 -128.9 37.04 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -110.85 20.85 17.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.459 ' CZ ' HG21 ' B' ' 27' ' ' THR . 36.0 t80 -57.13 114.87 2.33 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.617 0.722 . . . . 0.0 110.513 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -120.75 112.23 18.59 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.347 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.459 HG21 ' CZ ' ' B' ' 25' ' ' PHE . 38.8 p -153.18 149.72 22.29 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.37 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -52.58 141.25 53.29 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 C-N-CA 121.581 1.521 . . . . 0.0 110.629 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -117.0 82.38 1.8 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.991 0.424 . . . . 0.0 110.144 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.605 179.672 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.5 tp -106.85 -31.95 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.227 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 4' ' ' GLU . 18.3 m -63.16 -42.74 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.279 -0.168 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' N ' HG23 ' A' ' 3' ' ' VAL . 47.1 tp10 -69.26 -30.49 68.63 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.122 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -61.6 -46.84 88.13 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.185 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 18.8 p -74.1 -54.5 7.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.13 0.49 . . . . 0.0 110.987 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 92.9 m -143.38 168.14 20.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.893 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.37 81.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.863 0.363 . . . . 0.0 110.487 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -161.1 174.53 13.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.668 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t 62.15 42.19 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.154 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.9 t -148.29 117.19 6.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.424 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -115.7 156.47 25.88 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.522 0.677 . . . . 0.0 111.735 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -63.36 -27.13 69.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.413 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -58.44 -27.62 64.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.364 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -84.77 -23.38 29.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.814 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.44 -37.18 71.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.411 0.624 . . . . 0.0 111.339 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -76.87 -8.9 58.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.102 -0.953 . . . . 0.0 111.653 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -20.65 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.746 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.606 ' CZ ' ' SG ' ' A' ' 20' ' ' CYS . 2.4 p90 -130.21 -3.14 4.46 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 121.208 -0.197 . . . . 0.0 111.288 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.606 ' SG ' ' CZ ' ' A' ' 19' ' ' TYR . 41.7 m -118.46 162.26 18.63 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.732 0.301 . . . . 0.0 110.399 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.429 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -97.17 127.18 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.01 110.32 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.964 0.411 . . . . 0.0 110.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -60.28 156.37 15.72 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.584 0.706 . . . . 0.0 110.004 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -59.99 161.98 6.11 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.89 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 tp -162.54 132.27 4.46 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.628 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.39 122.11 45.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.972 0.415 . . . . 0.0 110.302 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.455 ' C ' ' N ' ' B' ' 10' ' ' HIS . . . -78.51 -50.22 6.24 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.666 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.479 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 38.2 t -49.26 -15.47 0.13 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.096 0.448 . . . . 0.0 110.481 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.455 ' N ' ' C ' ' B' ' 8' ' ' GLY . 68.1 m-70 -101.51 -38.48 7.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.619 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -63.1 -39.47 94.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.319 179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -45.02 -63.16 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.983 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.68 ' H ' ' CD ' ' B' ' 13' ' ' GLU . 1.5 pm0 -66.48 -37.12 84.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.874 0.369 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.446 ' O ' HG12 ' B' ' 18' ' ' VAL . . . -68.56 -18.8 64.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' B' ' 11' ' ' LEU . 57.2 tp -62.2 -45.82 91.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.394 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 9.4 p90 -86.64 -34.65 19.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.961 -178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.03 -46.8 85.85 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.221 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.564 HG13 ' N ' ' B' ' 19' ' ' CYS . 7.7 p -69.54 -46.79 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.031 0 CA-C-O 120.614 0.245 . . . . 0.0 110.97 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.564 ' N ' HG13 ' B' ' 18' ' ' VAL . 6.5 m -136.18 169.98 16.76 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.007 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.35 20.07 72.87 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.468 ' O ' ' N ' ' B' ' 23' ' ' GLY . 96.0 mt-10 -62.76 -41.19 99.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.617 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 41.03 24.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.593 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' B' ' 21' ' ' GLU . . . 59.94 -126.23 41.16 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.693 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 68.7 t80 -111.66 19.05 18.44 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.803 0.335 . . . . 0.0 110.349 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -55.42 114.06 1.67 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.272 -177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -99.15 116.67 31.9 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.243 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.69 158.05 21.67 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.353 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.07 144.36 46.88 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.861 1.707 . . . . 0.0 111.98 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -150.46 83.79 1.36 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.441 -179.884 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.487 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 tp -105.27 -29.02 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 120.672 0.272 . . . . 0.0 111.45 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 7' ' ' CYS . 20.1 m -60.36 -30.65 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.861 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.54 -18.68 65.5 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.052 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -65.75 -48.2 72.68 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.501 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.511 ' O ' ' SG ' ' B' ' 7' ' ' CYS . 10.8 p -85.69 -52.44 5.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -140.41 169.42 17.69 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.3 -53.1 31.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.018 0.437 . . . . 0.0 111.179 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -159.46 178.7 9.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.555 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t 53.14 41.68 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 110.927 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.3 t -143.93 118.23 9.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.241 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -115.31 154.23 29.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.67 0.748 . . . . 0.0 111.539 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 29.7 mt -76.46 -15.02 60.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.72 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.511 ' O ' ' CG ' ' A' ' 17' ' ' GLU . 3.0 m-85 -77.71 -34.02 52.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.313 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.817 ' C ' HE21 ' A' ' 15' ' ' GLN . 0.0 OUTLIER -89.71 -26.12 20.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.648 -179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.639 ' N ' HE21 ' A' ' 15' ' ' GLN . 19.8 mt -61.45 -28.03 68.99 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.147 0.498 . . . . 0.0 111.299 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 2.1 pt-20 -68.1 -16.3 63.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.915 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.547 ' ND2' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -57.64 -18.76 22.05 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.547 ' CD1' ' ND2' ' A' ' 18' ' ' ASN . 65.9 m-85 -91.67 2.41 56.49 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.726 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 17' ' ' GLU . 2.0 t -157.09 149.43 23.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.591 0.234 . . . . 0.0 110.615 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.085 -0.959 . . . . 0.0 110.59 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.86 131.05 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.222 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.633 HD22 ' N ' ' B' ' 3' ' ' ASN . 1.2 m120 -80.26 111.23 16.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.065 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -160.4 115.56 2.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.666 0.745 . . . . 0.0 109.887 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -116.51 163.14 16.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.64 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 tt -167.27 139.35 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -108.84 139.59 43.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.124 0.488 . . . . 0.0 109.81 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 -49.55 6.22 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.554 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 58.4 m -57.22 -34.21 68.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.457 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 6' ' ' CYS . 36.5 m-70 -73.57 -43.52 59.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.858 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.563 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -61.35 -40.23 93.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.63 -47.04 95.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.551 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 72.6 mm-40 -70.41 -38.84 74.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.992 0.425 . . . . 0.0 110.735 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.62 -7.38 58.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 tp -58.74 -39.06 79.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.143 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 1.7 m-85 -57.7 -47.84 81.23 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.39 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' B' ' 17' ' ' LEU . 3.4 mm? -63.59 -42.68 98.26 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.08 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 76.9 t -62.82 -46.1 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.649 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -154.96 159.25 40.25 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.264 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.42 ' O ' ' NH1' ' B' ' 22' ' ' ARG . . . 77.8 21.42 71.63 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.689 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.434 ' OE2' ' O ' ' B' ' 17' ' ' LEU . 96.8 mt-10 -57.65 -36.33 71.72 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.867 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.42 ' NH1' ' O ' ' B' ' 20' ' ' GLY . 93.0 mtm-85 48.44 35.18 5.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.035 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 68.79 -123.83 16.42 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.702 ' CD1' ' O ' ' B' ' 24' ' ' PHE . 0.5 OUTLIER -111.32 12.7 21.64 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -50.86 112.13 0.66 Allowed 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.261 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.411 ' O ' HG23 ' B' ' 27' ' ' THR . 33.6 t80 -84.12 104.04 13.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.651 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.411 HG23 ' O ' ' B' ' 26' ' ' TYR . 32.2 p -155.66 83.7 3.56 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.473 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' B' ' 30' ' ' ALA . 6.0 Cg_exo -63.91 141.85 79.51 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.862 1.708 . . . . 0.0 112.017 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.466 ' O ' ' CG ' ' B' ' 29' ' ' LYS . 11.3 pttm -55.41 80.75 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.516 0.674 . . . . 0.0 110.298 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 117.95 -1.024 . . . . 0.0 110.622 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tt -103.42 -26.98 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-O 120.576 0.227 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -59.66 -26.38 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.09 0.471 . . . . 0.0 111.056 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.46 -24.05 64.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.786 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -70.75 -42.69 70.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.53 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -73.38 -52.09 15.03 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.726 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 0.8 OUTLIER -142.02 -170.97 3.26 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.75 17.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.192 0.52 . . . . 0.0 111.605 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.416 ' OG ' ' N ' ' A' ' 10' ' ' VAL . 30.4 t -151.04 -174.53 4.83 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.416 ' N ' ' OG ' ' A' ' 9' ' ' SER . 33.7 m 40.53 42.43 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.0 t -127.63 120.1 27.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 m -113.46 153.25 28.98 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.788 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.2 mm? -75.05 -41.39 59.14 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -178.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.61 -42.25 96.45 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.775 HE21 ' N ' ' A' ' 16' ' ' LEU . 1.5 pp0? -61.91 -19.39 62.63 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.241 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.775 ' N ' HE21 ' A' ' 15' ' ' GLN . 53.7 tp -81.39 -26.11 35.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.571 0.224 . . . . 0.0 111.372 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.13 -29.5 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.614 ' ND2' ' O ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -49.8 -21.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.905 -0.318 . . . . 0.0 111.601 -178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.475 ' C ' ' CD2' ' A' ' 19' ' ' TYR . 11.0 p90 -119.54 -15.8 8.96 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.36 162.92 15.01 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.904 0.383 . . . . 0.0 110.79 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.534 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 72.5 t -91.66 130.56 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.251 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -85.29 105.14 15.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.658 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -162.42 121.04 2.2 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.019 0.824 . . . . 0.0 110.156 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -59.63 167.62 1.97 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 41.2 tp -167.25 138.75 3.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.324 0.583 . . . . 0.0 110.898 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.35 131.0 55.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.572 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.14 -52.56 3.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.907 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -64.76 -14.34 58.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.205 0.526 . . . . 0.0 112.294 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -85.21 -37.31 20.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 70.5 mt -63.04 -43.83 97.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.839 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.409 HG23 ' N ' ' B' ' 13' ' ' GLU . 5.1 m -69.98 -41.0 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.87 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.506 ' O ' ' CD1' ' B' ' 16' ' ' TYR . 93.0 mt-10 -62.87 -47.11 84.76 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.439 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.88 69.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.49 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.13 -50.29 74.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.52 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.506 ' CD1' ' O ' ' B' ' 13' ' ' GLU . 3.8 p90 -76.37 -23.13 54.12 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.88 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.507 HD13 ' O ' ' B' ' 17' ' ' LEU . 0.2 OUTLIER -63.78 -49.82 71.46 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.767 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.73 -50.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.504 ' O ' ' O ' ' B' ' 16' ' ' TYR . 20.9 m -101.01 169.16 9.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.453 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.47 13.89 79.44 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.79 -38.83 87.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.733 0.302 . . . . 0.0 111.37 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 81.9 mmt-85 44.35 33.22 0.82 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.39 -134.78 45.12 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.613 ' N ' ' CD2' ' B' ' 24' ' ' PHE . 0.1 OUTLIER -109.58 -13.45 14.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.893 0.346 . . . . 0.0 110.769 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -58.94 117.55 4.78 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.42 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -87.88 132.8 34.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.349 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.85 154.33 72.74 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.52 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -49.29 142.63 21.61 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.171 1.914 . . . . 0.0 111.835 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -134.39 83.61 2.05 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.379 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.616 -179.871 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 tp -107.31 -29.68 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.671 0.272 . . . . 0.0 110.498 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.52 -48.99 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.185 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -70.72 -15.66 62.71 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.507 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -75.9 -42.13 49.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.664 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -75.62 -54.87 6.29 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.542 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 1.2 m -145.42 172.41 13.23 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.72 -39.72 71.48 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 t -173.41 178.66 2.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 t 61.91 41.31 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.142 0.496 . . . . 0.0 109.742 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.2 t -129.36 116.82 19.63 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.222 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -114.91 128.89 56.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.798 0.808 . . . . 0.0 112.504 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -76.58 -50.31 14.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.693 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -62.62 -10.82 13.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.722 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' B' ' 16' ' ' TYR . 3.9 tp60 -72.57 -35.18 67.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.493 HD21 ' CG1' ' B' ' 12' ' ' VAL . 90.8 mt -62.03 -44.12 97.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.794 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -70.47 -35.48 73.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.162 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -45.54 -38.01 5.96 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.315 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -103.05 -57.75 1.99 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.999 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' LEU . 1.2 p -130.08 139.26 50.98 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 66.8 t30 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.528 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 56.9 t80 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 74.9 t -77.8 131.64 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -83.3 117.67 23.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.266 0.555 . . . . 0.0 111.817 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.77 137.77 55.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.683 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -60.23 155.54 17.32 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.334 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -169.74 129.75 1.0 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.948 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.33 168.25 20.23 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.421 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -62.06 -32.73 83.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.934 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.513 ' OG ' ' SG ' ' A' ' 6' ' ' CYS . 38.3 m -53.88 -26.28 24.09 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -74.27 -43.6 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.718 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 5.4 tp -65.75 -33.91 76.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.493 ' CG1' HD21 ' A' ' 16' ' ' LEU . 69.4 t -60.74 -46.63 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.671 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.575 ' O ' ' CE1' ' B' ' 16' ' ' TYR . 97.4 mt-10 -61.01 -59.14 5.85 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.13 -16.0 2.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.55 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.1 -8.88 1.67 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.207 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.575 ' CE1' ' O ' ' B' ' 13' ' ' GLU . 10.0 m-85 -49.14 -26.01 2.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.355 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.3 -41.8 98.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.446 0.641 . . . . 0.0 110.199 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.36 -40.83 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.912 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' B' ' 16' ' ' TYR . 73.6 m -91.67 169.91 10.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.491 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.85 19.48 73.48 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.38 -36.75 81.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 42.28 28.56 0.11 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.689 0.28 . . . . 0.0 110.682 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.17 -130.16 48.69 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.14 3.38 35.77 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.617 -0.343 . . . . 0.0 110.788 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -88.92 114.95 26.09 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.932 0.872 . . . . 0.0 111.897 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -106.25 124.06 49.01 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.764 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.36 150.28 23.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.025 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.21 142.35 36.36 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.278 1.319 . . . . 0.0 110.893 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -92.48 82.04 4.87 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.159 0.504 . . . . 0.0 109.946 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.068 -0.968 . . . . 0.0 110.537 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 tp -106.94 -31.17 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 120.599 0.238 . . . . 0.0 110.969 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 4' ' ' GLU . 8.1 p -64.13 -37.86 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.044 0.45 . . . . 0.0 110.419 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 3' ' ' VAL . 83.7 tt0 -67.48 -25.33 65.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.719 -179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -64.34 -46.12 84.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.478 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 7' ' ' CYS . 22.3 p -83.54 -52.53 6.4 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -142.34 169.96 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.06 -49.11 78.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.156 0.503 . . . . 0.0 110.952 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 t -158.05 177.08 11.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.502 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 52.06 41.47 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.081 0.467 . . . . 0.0 111.75 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.85 117.69 14.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.13 0.49 . . . . 0.0 110.319 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.3 m -115.93 157.93 23.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.521 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -63.2 -23.55 67.48 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.112 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.513 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 64.8 m-85 -59.42 -27.93 66.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.609 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.564 ' O ' ' NE2' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -86.11 -23.36 26.66 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.594 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' N ' HD12 ' A' ' 16' ' ' LEU . 10.9 mp -72.21 -34.37 68.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.097 0.475 . . . . 0.0 111.039 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 7.1 pt-20 -67.85 -13.08 61.85 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.015 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.805 ' H ' HD22 ' A' ' 18' ' ' ASN . 0.6 OUTLIER -67.76 -22.96 65.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.818 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 74.0 m-85 -104.76 -13.66 15.82 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 19' ' ' TYR . 72.4 m -155.07 172.71 17.68 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 110.908 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.661 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' B' ' 1' ' ' PHE . 60.5 t80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 77.5 t -93.81 129.91 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.904 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.16 128.88 34.84 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.341 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -157.01 114.29 3.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.459 0.647 . . . . 0.0 109.788 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -63.73 167.27 6.07 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.594 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 55.4 tp -154.44 129.64 9.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.083 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' B' ' 8' ' ' GLY . 37.5 t -151.34 169.39 22.09 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 111.048 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.647 ' N ' ' SG ' ' B' ' 7' ' ' CYS . . . -63.91 -28.62 73.0 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 63.0 m -50.48 -24.62 3.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -82.0 -39.94 22.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.044 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.571 HD13 ' O ' ' B' ' 11' ' ' LEU . 0.2 OUTLIER -62.94 -43.76 97.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.058 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 13' ' ' GLU . 33.0 m -68.4 -43.4 84.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.777 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.562 ' O ' ' CD2' ' B' ' 16' ' ' TYR . 81.8 mt-10 -56.83 -29.01 62.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.03 -45.67 9.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.65 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.422 ' C ' ' N ' ' B' ' 17' ' ' LEU . 55.8 tp -64.8 -34.64 78.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.441 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' B' ' 13' ' ' GLU . 0.1 OUTLIER -51.48 -11.65 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.025 -177.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.47 ' N ' ' CD2' ' B' ' 16' ' ' TYR . 52.4 tp -62.79 -44.63 95.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.59 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -91.27 -45.84 14.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 121.271 0.558 . . . . 0.0 110.392 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.492 ' SG ' ' N ' ' B' ' 20' ' ' GLY . 42.2 t -97.79 163.83 12.64 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.925 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.492 ' N ' ' SG ' ' B' ' 19' ' ' CYS . . . 76.62 20.73 76.19 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.43 -44.41 87.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 110.332 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 45.31 36.84 2.46 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.662 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.92 -158.58 38.83 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.688 ' O ' ' CD2' ' B' ' 24' ' ' PHE . 76.0 t80 -111.76 18.8 18.62 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.174 0.511 . . . . 0.0 110.084 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -55.35 113.11 1.28 Allowed 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.238 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -90.26 128.06 36.31 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 5.8 p -150.12 151.65 32.25 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.312 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' B' ' 30' ' ' ALA . 3.3 Cg_exo -50.43 138.59 38.55 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.913 1.742 . . . . 0.0 111.305 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.506 ' O ' ' CG ' ' B' ' 29' ' ' LYS . 9.8 pttm -54.87 81.93 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.7 0.762 . . . . 0.0 109.991 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' B' ' 28' ' ' PRO . . . . . . . . 0 C--N 1.318 -0.782 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.726 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.578 ' O ' HD13 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -107.69 -35.49 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.873 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 4' ' ' GLU . 7.7 p -60.4 -44.61 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.676 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' N ' HG13 ' A' ' 3' ' ' VAL . 42.6 tp10 -71.16 -32.52 69.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.119 0.485 . . . . 0.0 109.989 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' NE2' ' B' ' 10' ' ' HIS . 58.6 tt0 -62.48 -47.04 85.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.869 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -56.62 6.04 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.155 0.503 . . . . 0.0 110.184 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.0 m -145.98 168.57 20.56 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.648 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.47 -46.93 57.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.841 0.353 . . . . 0.0 111.717 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 p -161.25 172.27 16.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t 67.06 41.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 111.842 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.5 t -138.9 118.05 12.63 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 t -115.07 167.3 10.93 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.559 0.695 . . . . 0.0 111.474 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.7 ' H ' HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -61.33 -31.99 71.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.926 -1.033 . . . . 0.0 109.027 178.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -59.53 -35.5 74.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.46 -22.74 30.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.277 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.61 -40.6 92.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.723 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -72.42 -10.05 59.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.457 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 19' ' ' TYR . 47.2 t30 -64.27 -35.44 80.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.433 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 18' ' ' ASN . 53.5 m-85 -108.22 -26.63 10.48 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.716 0.293 . . . . 0.0 110.95 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.69 166.59 10.89 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.44 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 65.9 t30 . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.431 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . . . . . . . . . 2.2 p -71.04 128.71 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.429 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -89.55 106.11 18.24 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.219 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' B' ' 5' ' ' HIS . 0.0 OUTLIER -161.0 117.0 2.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.673 0.749 . . . . 0.0 109.567 179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.46 ' O ' ' NE2' ' B' ' 4' ' ' GLN . 68.9 t60 -90.18 144.02 26.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.156 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 71.5 mt -148.55 141.81 25.12 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.103 0.478 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -108.94 114.23 27.8 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.528 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.543 ' O ' HG23 ' B' ' 12' ' ' VAL . . . -73.51 -53.25 7.62 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.66 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 65.3 m -58.69 -33.35 70.05 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.424 ' NE2' ' O ' ' A' ' 5' ' ' GLN . 46.1 t60 -78.71 -44.97 22.33 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.699 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.08 -42.33 98.31 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 8' ' ' GLY . 43.2 t -60.79 -46.44 96.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.983 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.53 ' O ' ' CE2' ' B' ' 16' ' ' TYR . 96.9 mt-10 -70.29 -37.86 74.89 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.201 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.4 -8.8 59.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.657 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 tp -60.96 -46.03 92.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.509 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.53 ' CE2' ' O ' ' B' ' 13' ' ' GLU . 24.4 p90 -79.67 -21.64 44.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.61 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 46.5 tp -66.07 -47.37 74.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.24 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 59.0 t -81.05 -47.77 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.404 0.621 . . . . 0.0 110.263 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' B' ' 16' ' ' TYR . 1.1 m -103.91 155.02 18.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.124 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.21 19.43 72.11 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' B' ' 22' ' ' ARG . 97.6 mt-10 -56.83 -48.32 78.3 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' B' ' 21' ' ' GLU . 85.7 mtp180 38.49 38.39 0.24 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.922 0.392 . . . . 0.0 110.468 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.21 -119.87 12.47 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.713 ' CD2' ' O ' ' B' ' 24' ' ' PHE . 72.3 t80 -111.3 19.07 18.65 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 122.729 -0.277 . . . . 0.0 110.573 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.44 ' CE1' HG22 ' B' ' 27' ' ' THR . 30.2 t80 -54.18 112.33 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.678 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -94.42 132.06 39.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.624 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.44 HG22 ' CE1' ' B' ' 25' ' ' PHE . 1.4 p -139.81 158.44 67.73 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.098 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.64 143.75 82.14 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.274 1.983 . . . . 0.0 112.294 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -158.54 83.44 0.83 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.746 0.784 . . . . 0.0 110.027 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.8 0 CA-C-O 117.911 -1.042 . . . . 0.0 110.651 -179.747 . . . . . . . . 0 0 . 1 stop_ save_